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               Cellular proteins with antiviral properties have always been the priority area 
for researchers. Recent advances in the structural characterization of the proteins have 
provided a strong foundation towards these efforts. Human immune system act 
strongly against viral infection by up-regulation of certain proteins which are active 
against such infections. The present work is about two such cellular proteins, Viperin 
and VAPC, which show antiviral properties. Viperin (Virus inhibitory protein, 
endoplasmic reticulum associated, interferon-inducible), which is an evolutionary 
conserved gene and the research work done in past decade proves its antiviral 
activities against whole range of viruses ranging from DNA virus to RNA virus. But 
these studies lack structural and biochemical details about viperin. My Ph.D. thesis 
work showed for the first time that viperin is a radical SAM domain protein and it was 
done by systematic removal of N-terminal domain and reconstitution of purified 
protein under anaerobic conditions.  
             Another cellular protein, VAPC (vesicle-associated membrane protein-
associated protein (VAP subtype C) inhibits HCV virus by interaction with HCV 
unstructured protein NS5B. Our results indicate that VAPC is a member of 
intrinsically unstructured protein (IUP) with no secondary and tertiary structures. 
Extensive NMR characterization reveals that the C-terminal half of VAPC is involved 
in binding with NS5B and the isolated C-terminal 43 residues shows even tighter 
binding affinity with NS5B than the full length protein. The results demonstrate that 
the intrinsically unstructured VAPC form a “fuzz” complex with NS5B and also for 
the first time we designed a shorter VAPC-peptide which specifically bind NS5B with 
a Kd of 49.13 µM. In the future, functional characterization needs to be done to 
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1.1 Protein structure studies 
           The structure based approach to study the biological system has brought 
advances in understanding the important molecular mechanisms of biological system. 
Structural biology has shown explosive growth since late 1980s, with the number of 
high resolution structures of proteins added to the protein data bank (PDB) currently 
growing at more than 2000 per year (Kelly S.M. et.al. 2005). This has allowed much 
more detailed insights into the function of systems. Detailed protein structure and 
interaction studies constitute the foundation for novel drug discovery and drug design. 
Lots of techniques are available to study the proteins like, X-ray crystallography, 
NMR (Nuclear magnetic resonance spectroscopy), Electron microscopy (EM), 
Circular dichroism (CD), ITC (Isothermal calorimetry), Biacore and many more. 
NMR spectroscopy and X-ray crystallography are currently the powerful techniques 
capable of determining three-dimensional structures of biological macromolecules 
like proteins and nucleic acids at atomic resolution. This chapter gives description of 
NMR technique and usage in protein studies and a brief account about use of CD. 
            Few years back, X-ray crystallography was the main technique for protein 
structure studies and is superior to NMR in determining structures of much larger 
macromolecules, in a more automated way but since 1946, when the NMR was first 
used it has developed into premier organic spectrophotometric technique to study 
biomolecules. The important role of NMR in structural biology is illustrated by more 
than 6000 NMR solution structures deposited in the protein data bank. It has some 
advantages over X-ray crystallography technique. With NMR it is possible to study 
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the time dependent phenomenon. It allows the study of intramolecular dynamics in 
macromolecules, reaction kinetics, molecular recognition or protein folding.  
1.2 Features of NMR spectroscopy 
         Nuclear magnetic resonance spectroscopy is the technique to study physical, 
chemical, and biological properties of matter. NMR is a powerful analytical tool to 
study molecular structure including relative configuration, relative and absolute 
concentrations and intermolecular interactions. By using NMR spectroscopy proteins 
can be studied in solution state and conditions like pH, temperature and salt 
concentrations can be adjusted to mimic the physiological condition. NMR is able to 
characterize very weak interactions between macromolecules and ligands at atomic 
resolution by means of chemical-shift changes and makes this technique a major tool 
in rational drug design and discovery. 
1.2.1 NMR for proteins 
          The signals in NMR spectroscopy are referred to as resonances. Their positions 
in NMR spectrum depend on the local environment of nucleus producing the signal 
and referred to as chemical shifts reported in ppm. Protein structure study using NMR 
starts with assignment of maximum possible resonances of as many hydrogen, carbon 
and nitrogen on the protein of interest. The resonance of Cα, Cβ, Co and Hα depends 
on phi (φ)/psi(ψ) angle propensities (Spera S. et.al. 1991; Wang Y. et.al. 2002). The 
secondary and tertiary structure of protein is decided by its phi(φ)/psi(ψ) angle values. 
Figure 1.1 shows the possible φ/ψ values for different conformation of protein. So, it 
is the basic peptide bond structure which lays the foundation of protein structure 
studies by NMR.  The following section gives the brief overview of NMR in protein 
structure solution.  
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Figure 1.1 Dependence of secondary structure elements on Φ/Ψ angles. A) 
Representation of Φ and Ψ angles on peptide bond. B) Ramachandran plot shows the 
dependence of secondary structure elements on the Φ/Ψ angles. Adapted from Peti W. 
et al. (2000)   
1.3 Principle of NMR 
           All nucleons (neutrons and protons) composing any atomic nucleus, have the 
intrinsic quantum property of spin. This means they rotate around the given axis. The 
overall spin is determined by the spin quantum number I. Nuclei with even number of 
protons and neutrons (e.g. 12C, 16O, 32S)  have I = 0 and has no overall spin as their 
spins are paired and cancel each other. Isotopes with odd number of protons and/or 
of neutrons (1H, 13C and 15N) have an intrinsic magnetic moment and angular 
momentum, in other words a nonzero spin. Spinning charged particles are associated 





the rotating nucleus is described by a nuclear magnetic moment vector or microscopic 
magnetization vector µ, which is proportional to the spin angular moment vector. 
1.3.1 Larmor frequency 
            A nucleus with magnetic moment (µ), when placed in external magnetic field, 
orients opposite to the direction of external magnetic field, B (Figure 1.2) and precess 
around the axis of external magnetic field. This is called Larmor precession. The 
frequency of this precession is proportional to the strength of the external magnetic 
field and is a physical property of the nucleus with a spin. The precessional frequency, 
ω0 = γ B0, where γ is the gyromagnetic ratio and is constant for all nuclei of a given 
isotope.  
                                               
Figure 1.2 Spinning nucleus with a charge precessing in a magnetic field. Adapted 
from Van De Ven F. J.  (1995) 
Protons (1H) have a high natural abundance (99.9885 %) and gyromagnetic ratio is 
also high ((γ1H/γ13C is bout 4 and γ1H/γ13N is about 10) (Roberts, 1970), which makes 
them the most sensitive nuclei for NMR investigations. Introduction of 15N and 13C 
NMR active stable isotopes has made the structure studies of protein relatively easy. 
            There are some phenomenon in
required information about molecular stru
described below. 
1.3.2 Chemical Shift (δ) 
The resonance frequency depends upon the kind of nuclei (γ) and the external 
magnetic field (B0). Therefore, similar kind of 
frequency. But in biological samples we deal with
surrounded by different electronic densities.
electronic circulations, which in turn create an induced local magnetic field at the 
nucleus position. The tota
moment will therefore be reduced depending on strength of the locally induced 
magnetic field. Induced magnetic field is the characteristic of chemical nature of 
group, to which it belongs. This i
more commonly known as the chemical shift. It is one of the most basic parameter of 
NMR and is usually quoted in parts per million (ppm).
          
1.3.3 Coupling 
           Nuclei in molecules are not isolated and so the 
can interact between themselves. The phenomenon of 
through the polarization of the electrons in the orbitals 
scalar coupling or J-coupling. 
signal. The value of J is independent of the external magnetic field and its value 
decays to zero for nuclei separated by more than 4 or 5 bonds
 NMR, which when intelligently used,
cture and dynamics and some of those are 
nuclei would resonate at a same 
 “chemical” protons 
 The external magnetic field induces 
l effective magnetic field that acts on the nuclear magnetic 
s called a screening effect or shielding effect, or 
 
magnetic moments 
interaction between nuclei 
joining the two nuclei is called 
The coupling is observed by a splitting of the NMR 








phenomenon as it the basis of coherence transfer between nuclei, a crucial step in the 
development of two- and multidimensional NMR spectroscopy. J coupling along with 
chemical shift can produce characteristic patterns of couplings in many types of the 
amino acids, which are helpful to identify amino acid types. The size of the coupling 
depends on structural properties such as, dihedral angles (φ) (Figure1.3) via Karplus 
equation.            
                                          
                                                  Figure1.3 Dihedral angle (φ) 
To determine the torsion angles Ф and χ1, 3JNHHα and 3JHαHβ are used thus 
providing important information on conformations of peptide backbone and amino 
acid side chains. Deviation of 3JNHHα values from random coil values provides 
valuable secondary structural information. For α helices peptide segments where the 
ϕ- angle is around -60°, coupling constants is around 4 Hz, and it is between 8 and 12 
Hz for peptide segments in β-structures, where the ϕ- angle is in the -120° range. But 
for unfolded proteins it is estimated to be around 6~7.5Hz because of the averaging of 
coupling constant caused by conformational fluctuation (Dyson et al, 2004). 
1.3.4 Free Induction Decay (FID) 
          The nuclear magnetization perpendicular to magnetic field decreases with time 
and is measured in the receiver coil as fluctuating declining amplitude with time. This 
measures a frequency decay rate as a function of time (Figure 1.4). 
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          The FID is a function of time; the Fourier transformation converts this to a 
function of frequency. 
                                                     
Figure 1.4 Free induction decay, FID, is measured as a function of time in the x- and 
y-directions perpendicular to magnetic field. Adapted from Van De Ven F.J.  (1995) 
1.3.5 Relaxation 
          The NMR process is an absorption process. Nuclei in the excited state must also 
relax and return to the ground state and the timescale for this relaxation is crucial to 
the NMR experiment. The timescale for relaxation gives information about how the 
NMR experiment is executed and consequently, how successful is the experiment. T1 
and T2 (the inverses of the relaxation rates) are, respectively, the longitudinal (spin-
lattice) and transverse (spin-spin) relaxation times. 
1.3.5.1 Spin-lattice relaxation time (T1): In T1 relaxation time, longitudinal 
relaxation energy is transferred to the molecular framework (lattice) and is lost as 
vibrational or translational energy. The half-life for this process is called the spin-
lattice relaxation time. 
1.3.5.2 Spin-spin relaxation time (T2): In this process, energy transfer to the 
neighboring nucleus. The half-life for this is called spin-spin relaxation time. The 
peak width in an NMR spectrum is inversely proportional to the lifetime and depends 
on T2. These are influenced by the mobility in the solution, and so the molecular size 
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of the compound of interest. For large molecules T2 values reduces and the spectra 
produced is with broader lines. 
1.3.5.3 NOE (Nuclear Overhauser Enhancement) 
              This is also a kind of relaxation phenomenon and was discovered by Alber 
Overhauser in 1953. Nuclei close to each other in space transfer energy to each other 
during relaxation, and extent of transfer depends on the distance between the nuclei. It 
is normally detected between nuclei separated by a distance of less than 5Å. The NOE 
between two protons can be used to estimate the distance between them and is helpful 
in determining the two-dimensional and three-dimensional structure of the 
macromolecule (Figure 1.5) (Jeremy N.S Evans, 1995). NOE intensities are classified 
into three different categories, with distances of 1.8-2.7Å is classified as strong NOE, 
1.8-3.3Å as medium range NOE and 1.8-5.0Å weak or long range NOE. 
1.4 Structure details by NMR 
1.4.1 1-Dimension NMR 
        1-dimension NMR gives important information about protein stucture, whether it 
is folded or is unfolded. The figure (Figure 1.6) below shows the 1D spectrum of 
folded and unfolded protein. For folded proteins 1D spectra shows well dispersed 
peaks over the range of -1 to 12ppm and also presence of upfield peaks in 1D is the 
characteristic feature of folded proteins. While for unfolded proteins peak dispersion 




Figure 1.5.  NOE patterns associated with secondary structure. (A)  Broken  lines 
indicate  some  of the  NOE  interactions  that may  be  observable  in polypeptide 
chains.  (B) NOE intensities and NH-CaH J couplings in  several types of secondary 
structure.  The  thickness  of thc  horizontal  lines  indicates the  intensity  of the  
NOEs. (Adapted from Ad Bax 1989). 
nitrogens and carbons in a protein, peaks in 1-dimensional (1D) spectra of proteins are 
very overlapped. Peaks are clustered by type of proton, and cluster types are labeled 
in the spectrum (Figure 1.6). The overlapping in 1-dimension spectrum can be 
separated by adding 2-dimension and is done by using specific series of radio 
frequency (rf) pulses and delay in the transfer of magnetization from first nucleus to 





Figure 1.6 Comparison of NMR spectra of folded (top) and unfolded (bottom) protein 





N coupling for the heteronuclear NMR analysis 
              The one-bond coupling 1H-15N is the most basic experiment important for the 
heteronuclear NMR analysis of proteins and it arises because  the  magnetization  of  
the  first nucleus  is  sensitive  to  the  spin orientations  of  its  neighbors. It is 
considered the fingerprint of the protein. H-N bond is present in every amino acid 
residue except the N-terminal and the proline residues and (Figure 1.7) it  correlates  
the frequency  of  the  amide  hydrogen  with that of the amide nitrogen to produce a 
single  peak  for  each  residue  in  the protein  with  the  exception  of  prolines. 
Correlation spectroscopy method used to measure this coupling is called a 1H-15N 
HSQC spectrum (heteronuclear single quantum correlation). 
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Figure 1.7 A) Protein  backbone highlighting  the  amide  hydrogen/nitrogen  pair 
correlated  in  the  2D  [1H15N]-HSQC 
                     
(B) 2D [1H15N]-HSQC of protein. Through-bond correlation spectrum between the 
hydrogen (1H) and the nitrogen (15N) nuclei of amide groups in a protein. The 
location of the amide groups in the polypeptide backbone are sketched in the formulae 
on the left. The arrows indicate that each peak in the NMR spectrum corresponds to 
one NH-moiety. The axes of the NMR spectrum indicate the chemical shift of the 
hydrogen (1H) and the nitrogen (15N) nuclei. (Adapted from Wilder G. 2000) 
 
1.4.3 Sequential assignment 
            It is a process by which a particular amino acid spin system identified in the 










           Sequential assignments for protein sample with 15N and 1H nuclei can be done 
by the nuclear overhauser effect (NOE). In the two most common types of secondary 
structure (helix and beta) the peptide chain accommodates conformation which bring 
1H of the peptide backbone and the side chains of neighbouring residues so close 
together that they can be observable by NOE spectroscopy (Figure1.5). In the α-helix 
the neighbouring HN are 2.8 (Å) angström apart, and in the β-strand the distance is 
only 2.2(Å) angström. 
1.4.3.2 Heteronuclear sequential assignment 
             Along with 2D [1H,15N] HSQC, the sequence  specific  assignment  of  the  
hydrogen,  nitrogen  and  carbon resonances also involves 3D NMR experiments: the 
(HbHa)CbCa(Co)NH and the HNCaCb. These experiments helps to correlate the 
amide hydrogen and nitrogen frequencies with those of the Cα and Cβ  carbons. 
(HbHa)CbCa(Co)NH:  It measures the heteronuclear coupling between 1HN and 15N 
in one residue and the coupling across 13C to the 13Cα and 13Cβ in the preceding 
residue.  
HNCaCb: This particular 3-D experiment measures the one bond coupling between 
1HN and 15N and the one and two bond coupling between 15N and 13Cα and 13Cβ in 
one residue and also records the coupling across 13C to the 13Cα and 13Cβ in the 
preceding residue. 
The combined analysis of these 2 spectra helps in identification of the 13Cα and 13Cβ 
in the same residue and the preceding residue and thus helps to solve the backbone 
assignment (Figure 1.8). 
            
Figure 1.8 HNCACB and CBCACONH correlation. 
from 1Hα and 1Hβ to 13Cα and
here it is transferred first to
from Grzesiek S. et.al. 1992
1.4.4 Chemical shift analysis
         Chemical shift analysis of 
backbone can be used to determine the secondary structure type of a
segment either by plotting the secondary shifts (
shift) or by using the ch
using all of the secondary shifts from the Cα, Cβ and CO nuclei with an output of +1 
for beta-strand, 0 for random coil and 
Magnetization is transferred 
 13Cβ, respectively, and then from 13Cβ to
13CO, then to 15NH and then to 1HN for detection.
). 
 
1Hα and  13CO, 13Cα, and 13Cβ of the peptide 
 given peptide 
∆δ = observed shift –
emical shift index (CSI) and this gives a consensus value 
-1 for α-helix (Figure 1.10) 
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 13Cα. From 
 (Adapted 
 random coil 
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Figure 1.9 Chemical shift analysis of the peptide backbone NMR signals. Each panel 
represents a chemical shift analysis of the individual residues comparing the observed 
shift with the shift observed for the same residue type in random coil model peptides.  
(Adapted from Wishart D.S.et.al. 1994b) 
1.5 Structure Determination by NMR 
             Determination of protein structure by NMR depends in the assignment of 
NMR signals. NMR gives information about the structural geometry around the 
detected nuclei. From the NMR signals the distance to the near-by nuclei in the 
structure can be read using NOE spectroscopy, coupling constants and chemical shifts 
gives information about the dihedral angles, the relative angles of a number of bond 
vectors can be determined by residual dipolar coupling. All these constraints are 
utilized in the structure calculation. 
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          In the structure calculation process, the computer converts these conformational 
constraints into a visible structure. The computer program folds the starting structure 
in a way that the experimentally determined inter-proton distances are satisfied by the 
calculated structures. The computer program tries to calculate a structure with a 
possibly small overall energy.  
         The calculated structure should be analyzed for its structure quality and this is 
performed using the following three parameters: constraints violations, the RMSD 
(root mean square deviation) of the structure ensemble and the Ramachandran plot 
(phi and psi-angles of the protein backbone). The good quality structure should have 
little constraints violation, small RMSD and most phi and psi-angles should be within 
the allowed region of Ramachandran plot. PROCHECK is the most popular program 
for assessing the quality of a given protein structure (Laskowski et al., 1993). 
1.6 Outline of NMR experiment 
          NMR is a powerful technique to study structure of protein in 3-dimension or 
even in 4-dimension. The general outline to carry out NMR (Figure 1.11) experiment 
for protein is given below: 
i) The first step is the preparation of the protein sample in solution. The 
recombinant protein is expressed in medium enriched with 15N and/or 13C 
isotopes. The purified protein is dissolved in around 0.4-0.5 ml buffer 
containing 5%-10% D2O and after adjustment of pH, ionic strength, and 
temperature is analyzed by performing different NMR experiments.  
ii) The second step is to record high quality NMR spectra. A set of 
heteronuclear multidimensional experiments are recorded for chemical 
shifts assignments (1H, 15N, 13C).  
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iii) Assignment is the process of attributing a resonance in an NMR spectrum 
to a particular nucleus in a molecule. The first step is the identification of 
certain amino acids with a characteristic pattern of cross signals. The 
second stage of assignment is to search the sequential contacts from the 
already identified amino acids to the neighboring ones in the NOESY 
spectra. Inter-residual cross signals can be distinguished from the intra-
residual ones by comparing the NOESY with the TOCSY spectrum 
(Jeremy N.S Evans, 1995). 
iv) Next step is the collection of conformational constraints. 
v) Followed by 3D structure calculation. 
                               
Figure 1.10 Strategy of structure determination by NMR. Outline of the general 
strategy used to solve the three-dimensional structure of biological macro molecules 
in solution by NMR (Adapted from Wider G. 2000) 
1.7 Protein-ligand interaction by NMR 
           NMR spectroscopy has been widely recognized as an important tool for 
studying protein interactions (Zuiderweg 2002; Takeuchi and Wagner 2006). A range 
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of interaction partners can be studied by NMR and it may include macromolecules 
(proteins, nucleic acids and carbohydrates), molecular assemblies (cell membranes) 
and small molecule ligands. NMR spectroscopy gives quality information on binding 
site and mode, and it is also powerful for detecting interactions even between weakly 
binding components with dissociation constant Kd>10-4M (Vaynberg J. and Qin J. 
2006). 
1.7.1 Mapping of Chemical Shifts 
           Complex formation leads to selective changes in chemical shift of various 
nuclei which can be traced to get information of complex structure in the solution. 
Chemical shift mapping is commonly based on the 1H-15N HSQC, which is a 2-D 
spectrum containing one signal for each amino acid except proline. The signals of the 
amides which get perturbed by ligand binding will change position, on the addition of 
ligand. The perturbed residues can be mapped upon the protein structure to reveal the 
binding site/s in the protein. This approach has been widely used to study both 
protein–ligand and protein–protein interactions (Farmer B. T et. al. 1996; Williamson 
R. A. et. al. 1997; Lian L. Y et.al 2000). The rate constant for the formation of the 
complex and rate constant for the dissociation of the complex determines the 
equilibrium of the interaction when ligand binds to a protein. NMR can determine the 
reaction rate. 
             If the complex binds tightly, Kd<10
-7M, slow exchange conditions apply and 
chemical shifts from bound conformation and chemical shifts from free conformation 
can be observed (Lian L.Y. et.al. 1994). Whereas, for the complex with Kd>10
-3 M, 
the exchange rate is fast on NMR time scale and a single averaged resonance is 
observed for nuclei at corresponding sites in the free and bound species. 
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 The dissociation constant, Kd, is deﬁned as follows: 







And, complex concentration is given by, 
 =  ° + ° +  − ° + ° + 
 − 4°°                
          For slow exchange proteins, the signal of the protein ligand complex will 
increase with the addition of ligand and at the same time intensity of the free protein 
signal will decrease but the sum of the intensity of the two peaks will always be 
constant.  
1.8 CIRCULAR DICHROISM 
           Circular dichroism (CD) is the technique to study the conformations of 
peptides and proteins in solution (Alder A. J. et.al. 1973). It is a form of light 
absorption spectroscopy which measures differences in the absorption of left-handed 
polarized light versus right-handed polarized light by a substance which arise due to 
structural asymmetry. Three different wavelength ranges in CD gives great deal of 
details about a protein. These are; 
1. Far UV (190nm-250nm): in this range main contribution is by peptide bond. 
2. Near UV (250nm-300nm): dominated by aromatic amino acid residues. 




                                            
 
Figure 1.11 Far UV CD spectra associated with various types of secondary structure. 
Solid line, α-helix; long dashed line, anti-parallel β-sheet; dotted line, type I β-turn; 
short dashed line, irregular structure. Adapted from Brahms & Brahms (1980) 
            
          It has been shown (Figure 1.14) that CD spectra between 260 and 
approximately 180 nm can be analyzed for the diﬀerent secondary structural types: α-
helix, parallel and anti-parallel β-sheet, turn, and other. The application of CD for 
conformational studies in peptides (like proteins) can be largely grouped into i) 
monitoring conformational changes (e.g., monomer-oligomer, substrate binding, 
denaturation, etc.) and ii) estimation of secondary structural content i.e. amount and 
type of secondary structure. It is also an important method to study the stability of 
macromolecules by chemical denaturants or temperature stability. As addition of 8M 
urea to protein and studying it in near UV range will give details about the tertiary 
packing in the protein. 
           We have used the above mentioned techniques for the structural 
characterization and the interaction studies of two antiviral proteins, Viperin ((Virus 
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inhibitory protein, endoplasmic reticulum associated, interferon-inducible) and VAPC 
(vesicular associated membrane protein-associated proteins-C). These are cellular 
proteins and recent studies show their activity against virus propagation. We choose 
NMR as a tool as it is the only technique available to study unstructured proteins and 























            
 PART – I – Viperin a Radical-SAM protein 
                   
Chapter –2 
 BIOLOGICAL SIGNIFICANCE OF VIPERIN 
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2.1 Introduction 
              Secretion of interferons (IFNs) from viral infected cells is the hallmark of 
antiviral immunity. Cells that receive these signals, prepare the cells against infections 
by increasing expression of interferon stimulated genes (IFGs). Viperin (Virus 
inhibitory protein, endoplasmic reticulum associated, interferon-inducible), is one 
such gene which is induced by both type1 and type II interferon and is located at 
endoplasmic reticulum (ER) membrane. Viperin inhibits a number of RNA and DNA 
viruses.  
2.1.1 Viperin sequence details 
             Zhu et. al. in 1997 identified a gene by differential display analysis during the 
study of mRNAs which accumulates to enhanced levels in human cytomegalovirus 
infected cells. It was named as cig-5, cytomegalovirus induced gene-5. Further studies 
(Boudinot et. al. 1999) show that the rhabdovirus viral homorrhagic septicemia virus 
(VHSV) induces a gene in rainbow trout which was named as vig-1 (VHSV induced 
gene) and (Boudinot et .al. 2000) mouse dendritic cells infected with vesicular 
stomatitis virus (VSV) and pseudorabies virus (PrV) induces gene named as mvig. 
Similar gene was found in rat which was named best5 (Grewal et. al. 2000). All these 
genes have similar sequences and are induced by viral particles suggesting their 
functional importance. Later in 2001 Chin and Cresswell named it Viperin (virus 
inhibitory protein, endoplamic reticulum-associated, interferon-inducible). Homology 
study of human viperin (Figure 2.1.1) with mouse, rat (Best-5) and bony fish (vig-1) 
shows that the gene is evolutionary conserved among species as diverse as fish, 
rodents and primates, thus implying the conserved functionality of the gene. Sequence 
analysis of viperin suggests that it contain an N-terminal amphipathic domain which 
shows the least homology among the sequences from different species. N-terminal 
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contains leucine zipper which facilitates in protein-protein interaction or binding of 
protein to cell membrane.  Rest of the sequence shows more than 95% similarity with 
a middle domain containing CXXXCXXC motif which is conserved domain of the 
radical S-adenosylmethionine (SAM) superfamily protein and highly conserved C-
terminal domain. 
           Study done by Hinson and Cresswell (2009) show that viperin localize to the 
cytosolic phase of the ER through N-terminal amphiphatic α-helix. Upon over-
expression viperin alters ER structure by forming dimers and induces a tightly ordered 
array of ER membranes, which are called as crystalloid ER which reduces the 
secretion of soluble, but not membrane-bound proteins. N-terminal α-helix is 
necessary for ER localization of viperin and to inhibit protein secretion and this N-
terminal is important for its antiviral activity.  
            Later, it was found that this α-helix is required to localize viperin to lipid 
droplets and thus in HCV inhibition. But it has also been studied (Jiang D. et. al. 
2008) that although N-terminal is important for membrane association and for the 
antiviral activity, removal of N-terminal region does not completely abolishes the 
antiviral activity. The N-terminal truncated protein still can reduce HCV replication 
observed by cell colony formation. Trp-361, which is the last residue is very well 
conserved in all the species and mutating this residue to Ala, Asp and Pro completely 
abolish the antiviral activity of viperin but on mutating it to residues with aromatic 
ring like Phe and Tyr, it still retain the antiviral activity. This implies that all the 





              
 
Figure 2.1.1 Sequence comparison of human viperin, with sequence from mouse, rat 
(Best-5) and bonyfish (vig-1). The asterisks indicate amino acid residues that are 
identical in all four sequences. Residues in boxes represent highly conserved and 








2.1.2 Viperin in Immune response 
                 Viperin was initially identified as a human cytomegalovirus (HCMV) – 
inducible gene in primary skin cultures (Zhu et. al 1997). Recent investigations show 
that it interferes with the propagation of a broad spectrum of viruses, for example, 
Human cytomegalovirus (HCMV) (Chin & Cresswell 2001), Human 
immunodeficiency virus (HIV) (Rivieccio M. A et. al 2006 ), Hepatitis C virus (HCV) 
(Jiang. D. et. al. 2008), Alphavirus (Yugen Z et.al 2007), Influenza virus (Wang X et. 
al 2007), Sendai virus (Severa M. et. al. 2006), Vesicular stomatitis virus (VSV) 
(Boudinot et. al. 2000), Yellow fever virus (Svetlana F. K. et. al 2005) and also West 
Nile virus and Dengue virus (Jiang D. et. al. 2010) and thus suggesting its important 
role in innate immune response. Studies (Severa M. et. al. 2006) show that it is also 
induced by microbial products like lipopolysaccharide (LPS) and double-stranded 
RNA. Work done by (Helbig et.al 2005) shows that viperin has anti-HCV activity in-
vitro also. In HCMV infected cells, the expression of viperin down-regulates HCMV 
structural proteins (gB, pp28 and pp65), required for viral assembly and maturation 
(Chin & Cresswell 2001). In influenza A virus-infected cells, viperin prevents virus 
budding from the plasma membrane by disrupting the lipid rafts (10) and it does this 
by binding to and inhibiting Farnesyl pyrophosphate synthase (FPPS) which is a key 
enzyme in isoprenoid biosynthesis (Figure 2.1.2).  
          Viperin is active not only against viruses but also against bacteria. Work done 
on fish red drum Sciaenops ocellatus viperin gene (Sovip) indicate that Sovip is 
involved in host immune response during bacterial infection & by different bacterial 
pathogens it is differentially regulated at transcription level (Dang W. et. al. 2010). 
Viperin expression has also been noticed in inflammatory disease, atherosclerosis 
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(Olofsson P.S et. al. 2005). Most recent study (Hinson E. R et. al. 2010) shows that 
viperin is highly expressed in-vivo during acute lymphocytic choriomeningitis virus 
(LCMV) Armstrong infection in neutophils and macrophages and also in T-cells, B-
cells and dendritic cells but in chronic infection expression can only be detected in 
neutrophils and macrophages. Thus, indicating the role of viperin against bacterial 
and parasitic infections and showing viperin potential more against bacterial infection 
than viruses. Studies (Qiu L.Q et. al. 2009) on viperin knockdown mice show that 
Viperin facilitates T-Cell receptor mediated GATA-3 activation and optimal T-helper 
2 (Th2) cytokine production by modulating NF-κB (nuclear factor kappa-light-chain-
enhancer of activated B cells) and activator protein (AP-1) activities, thus is also 
involved in adaptive immune response.  
              Although viperin has been recognized for its incredible antiviral activities, 
study on Japanese encephalitis virus (JEV) (Chan Y.L, et. al. 2008) shows that virus 
can evade the antiviral effect of viperin. Viperin gene expression is highly induced by 
JEV but it is negatively regulated at protein level and it is due to the degradation of 
protein by proteosome pathway in JEV infected cells. 
             Over the past few years, significant research on viperin has proved its 
antiviral activity but the mechanism of its action since its discovery in 1997 against 
viral infection remains enigmatic 
2.1.3 Viperin Induction and Action 
                  Interferon stimulated genes (ISGs) are induced in two ways upon virus 
entry – IFN dependent induction and IFN independent induction. Viperin can also be 
induced by any of the two pathways depending upon the infecting virus (Rivieccio 
M.A. et al. 2006). Viral infection triggers up-regulation of IFN regulatory factor–3 
(IRF-3) which stimulates IFN production. IFN signaling through Jak-Stat pathway 
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activates formation of IFN stimulated gene factor-3 (ISGF3), which later on 
translocation to nucleus triggers IFN stimulated responsive element (ISRE). This up-
regulates several IFN-stimulated genes (ISGs) such as viperin (Figure 2.1.2). IRF-3 
can induce ISRE directly in IFN-independent pathway and its activation is enough to 
induce viperin gene expression. IRF-1 also induces viperin by IFN independent 
pathway. Viperin interacts with FPPS after migrating to cytosolic face of ER. Viperin-
FPPS binding disrupts the lipid rafts and increase membrane fluidity, thereby forming 
viral buds with daisy-chain like structures, which cannot be released from the plasma 
membrane (Wang et. al 2007). 
          
                                      




Figure 2.1.2 Schematic representation of immune response pathway that leads to the 
disruption of viral release from the plasma membrane. Red color represents FPPS, 
Green color represents Viperin.  (Duschene K. S et. al. 2010) 
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2.1.4 Influenza virus inhibition by viperin 
                 Although viperin has been widely studied for its antiviral activity but the 
mechanism of action is still ambiguous. Influenza virus infection kicks off with 
binding of HA (hemagglutinin) to the cell surface receptor, sialic acid. After 
attachment virus gets the entry inside the cell via clatherin mediated endocytosis. The 
low endosomal pH triggers the membrane fusion and release of viral genome into the 
cytosol and eventually to the nucleus, which is hijacked by the virus to synthesize its 
own mRNA and to replicate its genome. The viral mRNAs are later released into the 
cytosol for translation of viral transmembrane glycoproteins, HA (hemagglutinin), 
and NA (neuraminidase). These proteins traffic to plasma membrane lipid raft which 
is the important site for release of newly formed viral particles. Viperin effect is 
noticed (Wang X. et. al 2007) (Figure 2.1.3) at the release stage of influenza virus 
where virions on the surface of viperin expressing cells shows an abnormal stalk or 
chain like structure in which two or more viral particles are connected but cannot be 
released. The results suggest that viperin disrupts the lipid raft formation and which in 
turn lead to inhibition of release of viral particles and it does so by interacting with 
FPPS (Farnesyl pyrophosphate synthase) which is an important enzyme for 






              
 
Figure 2.1.3 Model diagram showing the Influenza A virus release upon viperin 
expression and interaction with FPPS. Left panel shows virus budding in the absence 
of viperin. Right panel shows IFN- induced viperin expression followed by its 
interaction with FPPS and disruption of lipid rafts and finally blockage of viral 
budding. (Adapted from Wang X. et.al. 2007) 
 
2.1.5 Radical SAM domain proteins 
              Radical S-adenosyl-L-methionine enzymes constitute a superfamily of 
enzymes which includes 2800 putative members from all three kingdoms of life. They 
are involved in numerous biosynthetic pathways. BioB (biotin synthase), LAM (lysine 
2,3-aminomutase), LipA (lipoate synthase) and MoaA (cofactor for molybdopterin 
biosynthesis) are few examples from this family. These enzymes catalyze diverse 
reactions but have one common function that all such enzymes contain i.e., [4Fe–4S] 
cluster which is coordinated by the cysteins from CXXXCXXC motif, which is the 
defining characteristic of these proteins. This motif is conserved in all radical SAM 
en-zymes required for the synthesis of molybdopterin (Mao A) (Figure 2.1.4 A), heme 
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D1 (NIRJ), and PQQ (PQQIII) [Sofia H.J. et.al. (2001) and Hanzelmann P. et. al. 
(2004)]. This family of enzymes requires SAM as cofactor to coordinate with the 
fourth free iron to make complete and functionally active [4Fe–4S] cluster (Figure 
2.1.4 B). As such viperin has been hypothesized as a radical SAM domain protein 
because of the presence of conserved SAM motif (CXXXCXXC) in the sequence. 
Below is the representation of typical chemical reaction catalyzed by radical SAM 
enzymes (Figure 2.1.4 D) (Layer G. et. al. 2004). The main steps of reaction are: 
1. First, the [4Fe-4S] center reduces to the +1 state by an external electron donor 
(usually flavodoxin). 
2. The electrons are transferred from reduced [4Fe-4S]1+ center to the sulfonium 
of SAM which undergoes hemolytic cleavage to methionine and a highly 
reactive 5’-deoxyadenosyl radical. 
3. A hydrogen is abstracted from an appropriately placed substrate (R–H) by 5’-
deoxyadenosyl radical, creating a substrate-based radical (R
·
 ) 
This free radical is further involved in catalyzing chain of reactions. 
                             
 
Figure 2.1.4 A) Conserved CX3CX2C motifs derived from the human viperin (hVip); 
cofactor for molybdopterin biosynthesis (MoaA); lysine 2,3-aminomutase (LAM); 
anaerobic ribonucleotide reductase (ARR); biotin synthase(BioB); and lipoyl synthase 
(LipA). (B) The structure of the MoaA [4Fe–4S] cluster incomplex with the ligand 
SAM.    
 
  (A) 
  (B) 
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Figure 2.1.4 C) The crystal structure of MoaA in complex with SAM (1TV8), with 
the region corresponding to the viperin C-terminus (214–361) colored in greencyan 
  
  
Figure 2.1.4 D) Schematic representation of SAM domain catalyzed reaction. 
Reaction steps common to all Radical SAM enzymes. First, an external electron donor 
(usually flavodoxin) reduces the [4Fe-4S] center to the +1state. Second, the [4Fe-
4S]1+center transfers an electron to the sulfonium of SAM causing the homolytic 
cleavage of SAM to methionine and a highly reactive 5’-deoxyadenosyl radical. 
Third, the 5’-deoxyadenosyl radical abstracts a hydrogen from an appropriately 
placed substrate (R–H),creating a substrate-based radical (R●). (Adapted from Layer 






             As described before Viperin is an important cellular protein which is 
evolutionary conserved in species from fish to primates. It has widely been accepted 
as a protein active against whole range of viruses, be it DNA virus or RNA virus. Its 
activity has also been noticed against bacteria and other pathogens, so is active in 
innate immune response also. However, so far there is no structure detail available 
about Viperin. The aims of this project are to:  
1.  Study the biophysical characteristics of this protein using techniques like CD 
and NMR. 
2. Study, if this protein is actually a radical SAM domain protein.  
           The results of this study will be of great contribution to unveil the 



















                             
 





2.2.1 Vector Construction 
            Total RNA was extracted from human Monocytic cells from HL-CZ cell line, 
using Qiagen RNeasy Mini kit and then the full-length viperin RNA was reverse-
transcribed into cDNA by RT-PCR using One-step RT-PCR kit (Qiagen). 
Subsequently, by using different pairs of primers, the 361-residue human viperin was 
dissected into 12 fragments, which include nine with the N-terminus differentially 
truncated, spanning over residues 11–361, 22–361, 36–361, 43–361, 45– 361, 54–
361, 60–361, 71–361 and 81–361, respectively, as well as N-terminal fragment (1–
72); putative SAM-containing region (71–213) and highly conserved C-terminus 
(214–361). The schematic representation of truncation sites in sequence is shown in 
Figure 2.2.1. Mutant construct of viperin 45-361 was constructed by replacing 
cysteins with alanine from conserved radical SAM domain motif CXXXCXXC by 
site directed mutagenesis. All the constructs were designed such that it has BamH1 
restriction site at N-terminal and Xho-1 restriction site at C-terminal. These fragments 
as well as the entire viperin were subcloned into His-tagged expression vector 
pET32a. The PCR product and vectors were double digested by BamH I and Xho I 
(New England Biolab) at 37℃ for 4 hours and subsequently purified by QIAquick Gel 
Extraction Kit (Qiagen). Ligation was then carried out at 16℃ overnight in the 
presence of T4 DNA Ligase (New England Biolab). The Colony screening was done 
by using E.coli DH5α for ligation. Plasmids were purified by QIAprep Spin Miniprep 
Kit 250 (Qiagen). All of the above experiments followed the protocols provided by 
the manufacturers. All the procedures were monitored by Agarose DNA 





    






2.2.2 Protein Expression and Purification 
2.2.2.1 Expression and purification of insoluble proteins  
                  The recombinant full length His-tag Viperin and also the truncated 
constructs were expressed in the bacterial strain BL21. A single colony was picked 
and inoculated to the ampicillin (final concentration of 100µg/ml) containing LB 
broth and kept in an incubator shaker at 37°C at 200rpm for overnight. This seed 
culture was used to inoculate 1L LB media (100µg/ml ampicillin) with ratio of 1:100. 
Briefly, the cells were cultured at 37℃ so as to reach OD of 0.6 at 600nm λ. The 
culture was then induced by IPTG with a final concentration of 0.4 mM and kept for 
expression for 16 hours at 20℃.  Cells were harvested by centrifugation at 6000 rpm, 
Beckman JA 8.1000 rotor and disrupted in lysis buffer [(50mM Tris-HCl buffer 
(pH7.5) with 150mM NaCl and 10mM β-ME)] by using ultra sonicator at 4℃. The 
lysate was discarded and the pellet was washed three times with TBS buffer [(50mM 
Tris-HCl (pH7.5) 150mM NaCl)] with 0.1% triton x-100 and then again washed with 
same buffer but without triton X-100. After every wash the suspension was 
centrifuged to separate pellet and supernatant. Finally, the pellet was dissolved in 8M 
urea and the supernatant was separated by ultracentrifugation at 18000rpm for 30 
minutes at 4°C. The supernatant of the centrifuged lysate was allowed to bind with 
Nickel beads resin.  The  resin  was  washed  with  buffer  A  [8M urea, 50mM  Tris-
HCl  (pH  8.0), 150mM  NaCl, 20mM  imidazole]. Protein was eluted from Nickel 
bead resin by elution buffer (buffer A with 250mM imidiazole). Elute was further 
purified by HPLC puriﬁcation on a reverse-phase C4 column (Vydac). The identities 




2.2.2.2 Expression, Purification and Reconstitution of the [Fe4–S4] cluster in 
Viperin (45–361) 
             Recombinant containing a putative SAM domain was also expressed the same 
way as other constructs but with the exception of media content. The LB media for 
Viperin (45–361) was supplemented with 0.15mM FeCl3 to facilitate the 
reconstitution of [Fe4–S4]. Brieﬂy, the cells were cultured at 37°C to an OD 600 of 0.6 
and then IPTG was added to a ﬁnal concentration of 0.4mM to induce expression of 
the recombinant proteins for 5h at 30°C. Cells were harvested by centrifugation at 
6000 rpm, Beckman JA 8.1000 rotor and disrupted in lysis buffer [(50mM Na2HPO4 
(pH  6,5), 150mM  NaCl, 20mM  imidazole, 10mM β-ME and 10% glycerol] by using 
ultra sonicator at 4℃. The supernatant of the centrifuged lysate was allowed to bind 
with Nickel beads resin and on elution was subjected to FPLC puriﬁcation using a gel 
ﬁltration column (HiLoad 16/60 Superdex 200). Unfortunately initial experiments 
were performed under aerobic condition. As a result, the protein samples puriﬁed 
under aerobic condition was colorless, indicating no formation of the [Fe4–S4] cluster. 
Further reconstitution following the previous protocol (Paraskevopoulou C. et. al. 
2006) also failed under aerobic condition. Moreover protein tends to precipitate 
during purification and was highly unstable. To overcome this, viperin (45–361) after 
binding to nickel resin was purified in anaerobic chamber (DW Scientiﬁc MACSMG-
1000 anaerobic chamber). All the buffers used were degassed by purging with 
nitrogen (N2) gas. In the anaerobic chamber the  resin  was  washed  with  buffer  A  
[50mM  Na2HPO4 (pH  6,5), 150  mM  NaCl, 20 mM  imidazole, 10mM β-ME and 
10% glycerol] and after in-gel digestion with thrombin for 4hrs at room temperature 
was eluted with buffer B [50  mM  Na2HPO4 (pH  6,5), 500  mM  NaCl, 10mM β-ME 
and 10% glycerol]. The eluate this time was yellow in color, indicating the formation 
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of the [Fe4–S4] cluster to some extent. As such, the reconstitution was further 
performed under anaerobic condition by incubating the puriﬁed Viperin (45–361) 
protein with 10 mM DTT for 30 min, followed by further incubation for 1 h in the 
presence of Na2S and (NH4)2Fe(SO4)2 at a 10 M excess (C. Paraskevopoulou et. al.). 
The reconstituted protein was desalted by buffer-exchange in Amicon centrifuge tubes 
with a molecular weight cutoff of 10KDa. The identity of recombinant protein was 
veriﬁed by MALDI-TOF mass spectrometry and also the protein sequence of Viperin 
(45–361) was further conﬁrmed by sequencing 75 overlapped trypsin-digested peptide 
segments with mass spectrometry on a Micromass Q-TOF 2 machine.  
2.2.3 Media prepration for NMR sample 
              For heteronuclear NMR experiments, 15N-labeled proteins were prepared 
following the similar expression and puriﬁcation procedure except for growing E. coli 
cells in M9 medium. E.coli cells in the M9 minimal medium (Na2HPO4•12H2O 
17.1g/L (sigma); KH2PO4 3g/L (sigma); NaCl 0.5g/L; (15 NH4)2SO4 1g/L 
(Cambridge Isotope Laboratories Inc.); Glucose 4g/L (Sigma); MgSO4 1mM (Merck); 
Thiamine 2mg/L (Sigma); ampicillin 75mg/L). The (15NH4)2SO4 salt was used for 
15N-isotope labeling  
2.2.4 UV–visible Spectroscopy  
              UV–visible spectra for viperin (45-361) were collected on a Nicolet 
evolution 300 spectrophotometer with a wavelength ranging from 295 to 585nm.  
2.2.5 Circular dichroism (CD)  
                All CD experiments were performed on a Jasco J-810 spectropolarimeter 
equipped with a thermal controller using 1mm path length cuvettes. Viperin (45–361) 
was dissolved in 10mM phosphate buffer (pH 6.5). However, the C-terminus Viperin 
(214–361) was insoluble in buffers and consequently was solubilized in salt-free 
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water (pH 4.0). The far-UV CD spectra were recorded at protein concentrations of 
20µM while the near-UV CD spectra were recorded at protein concentrations of 
100µM at 25°C. The thermal unfolding was conducted from 15°C to 95°C. Final CD 
spectra were obtained by adding and averaging data from three independent scans. 
Estimation of the secondary structure contents by deconvoluting far-UV CD spectra is 
performed with the CDPro software package 
(http://lamar.colostate.edu/;sreeram/CDPro). 
2.2.6 NMR sample prepration 
              NMR samples were prepared by buffer-exchanging the proteins into 
phosphate buffers (pH 6.5) for Viperin (45–361) or by dissolving the powers into 
Milli-Q water for Viperin (214–361) and Viperin (71–361) at pH 4.0, with an addition 
of 50 µL of D2O into 450 µL samples for NMR spin-lock. The final protein 
concentration for 1D and 2D experiments was 100µM. One-dimensional (1D) 1H 
NMR and two-dimensional (2D) 1H–15 N HSQC experiments were acquired on an 
800MHz Bruker Advanced spectrometer equipped with pulse ﬁeld gradient units at 




























2.3 Structure details of Viperin  
2.3.1 Structural characterization of the human viperin fragments  
              The experiments were done by cloning the full-length viperin and its 12 
dissected fragments into His-tagged expression vector. However, the full length 
viperin was found not to be expressed. For other fragments, only ﬁve were 
expressible, which include fragments (43–361), (45–361), (71–361), (81–361) and 
(214–361). Table 2.3.1 gives a description of constructs made and expression pattern, 
whether in the soluble fraction or insoluble fraction. Out of them, the fragments (71–
361), (81–361) and (214–361) were only found in inclusion body and could not be 
refolded by fast dilution or dialysis against various buffers. Viperin (43–361) was 
found to be partly in supernatant but the puriﬁed protein was very unstable, which 
was prone to aggregation even at very low concentrations (<20µM). Interestingly, the 
majority of the recombinant Viperin (45–361) protein existed in supernatant and 
consequently it was puriﬁed by Ni2+-afﬁnity column under native condition, followed 
by FPLC puriﬁcation after the thrombin cleavage to remove His-tag. From 1 liter 
culture 10mg of purified protein was obtained in approximately 100µl of buffer 
solution.The FPLC and DLS profiles (Figure2.3.1) show that the protein is 
homogenous and is monomeric. Moreover, its protein sequence was also conﬁrmed 









   
Table 2.3.1 Brief description of truncated fragments of Viperin with their expression 
patterns and the techniques used to study the purified protein. 
   
                    Figure  2.3.1A) FPLC purification profile of Viperin (45-361) 
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                           Figure 2.3.1B) DLS profile of Viperin (45-361) 
            As presented in Figure 2.3.2 A, although expressed in the medium without 
FeCl3 and puriﬁed under aerobic condition, the recombinant Viperin (45–361) protein 
has a far-UV CD spectrum with one positive signal at 197 nm, and two negative ones 
at 208 and 222nm, respectively, indicating the presence of a large fraction of α-helix 
secondary structure. Indeed, further analysis of the CD spectrum indicates that the 
unconstituted Viperin (45–361) already contains 65% α-helix; 19% β-strand/turn and 
16% unordered secondary structures. However, the unconstituted protein was unstable 
and prone to aggregation. For example, during the thermal unfolding at a protein 
concentration of 20 µM, precipitation started at 30°C and almost completed at 45°C 
(Figure 2.3.2 A). On the other hand, Viperin (45–361) appears to have considerable 
tertiary packing as evident from a dramatic difference between its near-UV spectra in 
the absence and presence of 8 M urea (Figure 2.3.2 B). Furthermore, the unconstituted 
Viperin (45–361) seems undergoing conformational exchanges on µm–ms time scale 
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or/and dynamic aggregation over some regions. Consequently no very up-ﬁeld peak is 
observed located closed to or less than 0ppm in its 1D NMR spectrum and HSQC 
peaks can only be detected for a small portion of residues (Figure 2.3.2 C). For 
instance, only one peak is visible for ﬁve Trp side chains in Viperin (45–361). 
 
 
Figure 2.3.2 Characterization of Viperin (45–361) puriﬁed under aerobic conditions 
(A) Far-UV CD spectra of Viperin (45–361) at a concentration of 20µM in 10mM 
phosphate buffer (pH 6.5) at different temperatures. The spectrum at 15°C is colored 
in blue and that at 95°C is in red. Inlet: thermal unfolding curve as monitored at 222 
nm. (B) Near-UV CD spectra of Viperin (45–361) at a concentration of 100µM in 
10mM phosphate buffer (pH6.5) at 25°C in the absence (blue) and presence of 8M 
urea (red).  
 
2.3.2 Reconstitution of the [4Fe–4S] cluster in Viperin (45–361) and viperin (45-
361) mutant 
               Since viperin has been hypothesized to be a radical SAM enzyme, we thus 
attempted to reconstitute the [Fe4–S4] cluster in Viperin (45–361). Initially 
experiments were conducted under aerobic condition and consequently the 
reconstitution failed. However, when experiments were performed under anaerobic 
condition, the Viperin (45–361) sample puriﬁed from E. coli cells cultured in the 
medium containing FeCl3 is yellowish (Figure 2.3.3A). This implies that the sample 
may already gain a small amount of the [Fe4–S4] clusters. Therefore, we further 
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conducted the reconstitution under anaerobic condition by incubating Viperin (45–
361) with 10mM DTT for 30 min, followed by further incubation for 1 h in the 
 
 
Figure 2.3.2(C) 1H–15N heteronuclear single quantum correlation (HSQC) spectrum 
of Viperin (45–361) at a concentration of 100µM in 10mM phosphate buffer (pH6.5) 
at 25°C. The green arrow is used to indicate the peak resulting from the side chain of 
Trp residue 
 
presence of Na2S and (NH4)2Fe(SO4)2 at a 10M excess (C. Paraskevopoulou et. al. 
2006) and was spinned down at 3000 rpm for 10min. to remove any precipitation. 
Strikingly, the reconstituted sample becomes brownish (Figure 2.3.3A), indicating 
that the [Fe4–S4] cluster has been successfully reconstituted in Viperin (45–361). The 
similar studies when done with Viperin mutant it didn’t show any brown color 
formation, indicating the importance of CXXXCXXC motif in the chemistry of 
radical SAM domain protein.  
             Further evidence for [Fe4–S4] cluster formation in the reconstituted viperin 
(45-361) was confirmed by the UV–visible spectroscopic characterization (Figure 
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2.3.3 B). The reconstituted sample has the absorption property characteristic of [Fe4–
S4] clusters: a shoulder at 325nm and a broad peak at 415nm. By contrast, the sample 
puriﬁed under aerobic condition has no absorption at the two wavelengths. 
Interestingly, the unconstituted sample but puriﬁed under anaerobic condition also has 
the two peaks but their intensities are much smaller, indicating the presence of a small 
amount of residual [Fe4–S4] clusters only. Lack of infrastructure for Electron 
Paramagnetic resonance (EPR) spectroscopy hindered our future experiments for the 
more convincing results regarding the Radical SAM chemistry of viperin but UV-
visible spectroscopy, Circular dichroism together with NMR help us to give 
convincing results to prove the radical SAM behavior as well as for the structure 
characterization of viperin. Notably, as revealed by deconvoluting the far-UV CD 
spectrum (Figure 2.3.3C), the reconstituted Viperin (45–361) has a higher content of 
ordered secondary structures than unconstituted one, with 70% α-helix; 25% β-
strand/turn. This suggests that the reconstitution of the [Fe4–S4] cluster can induce 
further formation of the ordered secondary structures from unordered regions in 
Viperin (45–361). Furthermore, upon reconstitution, the thermal stability of Viperin 
(45– 361) increased. The reconstituted sample started to precipitate at 45°C (Figure 
2.3.3 C) while the unconstituted one began at 30°C (Figure 2.3.2 A). In particular, the 
very up-ﬁeld NMR peaks are observed for samples 2 and 3 (Figure 2.3.3 E), but not 1, 
indicating that the reconstitution also triggered the formation of the tight tertiary 
packing. As such, the very broad NH peaks may mostly result from the paramagnetic 
effect of Fe ion. 
               Viperin (45–361) was characterized by CD spectroscopy to have largely 
formed secondary structures and considerable tertiary packing even before the 
reconstitution of the [4Fe–4S] cluster. This implies that the unconstituted Viperin 
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(45–361) may already adopt the overall fold common to radical SAM enzymes, which 
contains a large content of a-helix, as shown by the MoaA structure (Figure 2.1.4 C). 
However, the unconstituted Viperin (45–361) appears less stable and is more prone to 
aggregation than the reconstituted one. 
          
 
Figure 2.3.3 Characterization of Viperin (45–361) after reconstitution (A) NMR 
samples of Viperin (45–361) puriﬁed under aerobic (1); anaerobic condition (2); and 
after reconstitution (3) (B) UV–visible spectra (295–585nm) of different Viperin (45–
361) samples at protein concentrations of 30 µM, puriﬁed under aerobic (1, black); 
anaerobic conditions (2, blue) and after reconstitution (3, red) 
 
Figure 2.3.3 C) Far-UV CD spectra of Viperin (45–361) after reconstitution at a 
concentration of 20 µM in 10mM phosphate buffer (pH 6.5) at different temperatures. 
The spectrum at 15°C is colored in blue and that at 95°C is in red. Inlet: thermal 
unfolding curve as monitored at 222nm. (D) Near-UV CD spectra of the reconstituted 
Viperin (45–361) at a concentration of 100µM in 10mM phosphate buffer (pH 6.5) in 




    
Figure 2.3.3 E) One-dimensional 1H NMR spectra of Viperin (45–361) at 25°C and a 
concentration of 250µM in 50mM phosphate buffer (pH 6.5) containing 500mM 
NaCl, 10%Glycerol, 10mM β-ME, 3mM DTT; puriﬁed under anaerobic conditions 
(upper panel) and after reconstitution (lower panel). The red arrows indicate the very 
up-ﬁeld NMR resonance peaks. 
2.3.3 Structural characterization of the buffer-insoluble Viperin (214–361) 
                 Since the C-terminal region is highly conserved within all viperin proteins 
but has no signiﬁcant homology with other proteins, here we present the detailed 
characterization of the human Viperin (214–361) by CD and NMR spectroscopy. 
Viperin (214–361) was highly expressed in E. coli cells but all existed in inclusion 
body. As such, we puriﬁed the fragment ﬁrst by Ni2+-afﬁnity column under denaturing 
condition, followed by HPLC puriﬁcation on a C4 column. Intriguingly the 
lyophilized powder of Viperin (214–361) was insoluble in buffers but again could be 
dissolved in salt-free water (pH 4.0) at a protein concentration even up to 1mM. As 
seen in Figure 2.3.4A, Viperin (214–361) in salt-free water has a far-UV CD spectrum 
with a positive signal at 192nm and two negative signals at 207 and 220 nm, 
respectively. Deconvolution of the CD spectrum indicates that it contains 24% α-
helix; 16% β-strand/turn and 60% unordered secondary structures. Furthermore, 
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Viperin (214–361) showed no precipitation during thermal unfolding even up to 
95°C. Noticeably, as judged by the far-UV CD spectrum (Figure 2.3.4A), even at 
95°C its structure is not completely random coil. On the other hand, the non-
cooperative unfolding curve implies that Viperin (214–361) has no tight tertiary 
packing. Also it is worthwhile to note that introduction of salt signiﬁcantly induces 
the aggregation of Viperin (214–361) even at a protein concentration of only 20mM. 
At 12mM NaCl, almost all protein precipitated (Figure 2.3.4B). Consistent with CD 
results, the small HSQC spectral dispersions (Figure 2.3.4C) again indicate that 
Viperin (214–361) has no tight tertiary packing. Interestingly, for Viperin (214–361) 
HSQC peaks can be detected for all three Trp side chains (Figure 2.3.4C). Similar 
results were obtained for viperin 71-361 construct which constitutes SAM domain and 
C-terminal domain (Figure 2.3.5). HSQC spectrum for this construct shows very 
small dispersion and only 1 Trp residue peak can be seen.  
              
Figure 2.3.4 Characterization of Viperin (214–361) solubilized in salt-free water. (A) 
Far-UV CD spectra of Viperin (214–361) at a protein concentration of 20µM in salt-
free water (pH 4.0) at different temperatures. The spectrum at 15°C is colored in blue 
and that at 95°C is in red. Inlet: thermal unfolding curve as monitored at 222nm. (C) 
Far-UV CD spectra of Viperin (214–361) at a protein concentration of 20µM at 
different concentrations of NaCl (0, 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 10 and 12 mM) at 
25°C. The spectrum in salt-free water (pH 4.0) without addition of NaCl is colored in 
blue while that with a ﬁnal NaCl concentration of 12mM is in red. The Viperin (214–





        Figure 2.3.4 (B) 1H-15 N HSQC spectrum of Viperin (214–361) at a protein   
concentration of 1mM in salt-free water (pH 4.0) at 25°C 
         
Figure 2.3.5 
1H-15N HSQC spectrum of Viperin (71–361) at a protein concentration 
of 100µM in salt-free water (pH 4.0) at 25°C. 




            Interferons (IFNs) initiate the first line of defense against viral infection and 
they do so by stimulating hundreds of interferon stimulated genes (IFG’s) present in 
the system. Viperin is an example of one such gene which is highly inducible by both 
type I and type II IFNs. The key role of viperin in innate immunity is strongly 
implicated by its evolutionary conservation across both mammals and lower 
vertebrates and its antiviral activity has constantly been proved against whole range of 
viruses. This extra ordinary activity of viperin can be of great interest to target for 
drug discovery. It can be a wonder drug like penicillin, which is a potent antibiotic 
against almost all bacteria.  
            Since the discovery of Viperin in 1999, a lot of research work has been done 
on it to access its antiviral or antimicrobial activities against different infectious 
agents but there is no work reported for the structure or biophysical studies of this 
protein. Therefore, we initiated the present structural study on the viperin protein in 
an original attempt to determine its structure. Although we have not solved the 3D 
structure of viperin but our attempt to study the structure by CD and NMR shows that 
viperin is a well folded protein. Based on the presence of a characteristic CX3CX2C 
motif, it was extensively hypothesized that viperin might be a radical SAM enzyme. 
However, previous attempts to reconstitute the [4Fe–4S] cluster in viperin all failed. 
In the present study, by a systematic dissection of viperin into 12 fragments, the 
Viperin (45–361) fragment only with the N-terminal transmembrane helix deleted has 
been successfully identified to be soluble and structured in buffers. The successful 
attempt to reconstituting the [4Fe–4S] cluster in Viperin (45–361) under anaerobic 
condition provides the first experimental evidence confirming that viperin is indeed a 
radical SAM enzyme. This finding is novel and quite important to study the 
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mechanism of viperin activity. Our findings show that the un-reconstituted protein is 
unstable and tend to aggregate soon while reconstituted protein is more stable. 
                In different radical SAM enzymes, the region corresponding to Viperin 
(214–361) is highly variable and recognized to be responsible for binding to specific 
substrates. The experiments here demonstrate that despite having some helix 
secondary structure, the Viperin C-terminus over residues 214–361 is only soluble in 
salt free water but not buffers. Furthermore, as revealed by CD analysis, a large 
portion of Viperin (214–361) appears to become unfolded upon being isolated from 
Viperin (45–361). The high insolubility of Viperin (214–361) in buffers is caused by a 
significant exposure of the hydrophobic side chains to bulk solvent, which likely 
results from the inappropriate dissection. If Viperin (45–361) adopts the SAM enzyme 
fold, the C-terminal residues over 214–361 should have extensive packing 
interactions with residues over 45–361. Consequently, the dissection of Viperin (214–
361) will result in a dramatic loss of these packing interactions, thus leading to the 
unfolding of some regions, as well as a significant exposure of hydrophobic side 
chains. Taken together, the results from the present study imply that most residues of 
Viperin (45–361) may be required to form the SAM enzyme fold, which is not further 
dissectible. This speculation is further supported by detailed CD and NMR 
characterization of another fragment, Viperin (71–361). Viperin (71–361) was also 
insoluble in buffers but again could be dissolved in salt-free water at high protein 
concentrations. Similarly, Viperin (71–361) is only partially folded in salt free water, 
with no tight tertiary packing. 
2.3.5 Future Work 
             Studies show that viperin inhibits several viruses in vitro but still viruses can 
evade immune response caused by it. Future work should be done to get a better 
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perspective about it. Viperin is very active against viruses but its mechanism of action 
is still not clear. Our work shows that it is a radical SAM enzyme. To uncover the 
molecular mechanism by which viperin functions, it is important to identify the 
chemical reactions catalyzed by viperin. It may be the chemical molecules catalyzed 
by Viperin radical SAM enzyme, which are responsible for its antiviral activity or 
some pathway controlled by viperin carrying out the antiviral function. Moreover, the 
chemical molecules formed in the catalytic reaction by viperin may bear key 
information for further design of antiviral drugs of significant therapeutic 
applications. Also, structure studies of viperin along with binding partner, FPPS can 
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           What is Hepatits C? Hepatitis C is an infectious disease caused by Hepatitis C 
virus, causing liver inflammation. It was first discovered in mid 1970s by Alter H.J. 
and group. He and his research team found that most post-transfusion hepatitis cases 
were not due to hepatits A or B and named as “non-A, non-B hepatitis” (NANBH). 
For a decade there was no progress in identification of virus but then in 1989 Choo Q. 
L. and team isolated HCV virus genome for the first time using random polymerase 
chain reaction (PCR) assays in plasma of Chimpanzee chronically infected with non-
A, non-B hepatitis and hence the virus was renamed as Hepatitis C virus. 
               Hepatitis C virus infection is a global problem infecting millions of people 
worldwide. According to World Health Organization (WHO Fact sheet N°164) it 
infects 170-180 million people globally which accounts to about 3% of world’s 
population (Figure 3.1.1). Every year 3-4 million people get infected with HCV and 
350,000 dies of infection. It is the major reason for liver transplants. As per WHO 
2010 report about 1% of Singapores population which estimates to 46090 individuals 
are infected with HCV.  
3.1.1 Acute and Chronic Hepatitis 
           Acute hepatitis C infection is asymptomatic, means no visible symptoms of 
disease can be detected. 15-25% of individuals infected with HCV clear the virus 
from the body during the acute phase while rest develops with chronic hepatitis.  
            Chronic infection is often asymptomatic until extensive liver damage has 
occurred. Chronic infection leads to cirrhosis, hepatocellular carcinoma, and hepatic 
 failure.  Within span of  few years 10
cirrhosis  and  1-5%  develop  liver cancer    (Centers  for  Disease  Control  and  
Prevention,  1998).  HCV
liver transplantation among adults.
Figure 3.1.1 HCV global prevalence 2010 (%)
3.1.2 HCV Genotype  
            HCV is a single
Flaviviridae family. This family also includes
dengu virus and yellow fever virus.
(Lindenbach et.al, 2007
surrounded by icosahedral protein envelope followed by lipid envelope of cellular 
origin. The virus has considerable genetic diversity. 
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sequence is between 20-25% (Simmonds P et. al. 2005). The geographical 
distribution of genotypes is different (table 3.1). Genotype 1 and 2 are broadly 
distributed throughout the globe, and are the dominant genotypes in Europe, North 
America and Japan whereas in Asia it is genotype 6 which is prevalent. The 
geographical distribution of genotypes is important as different genotypes respond 
differently to the available HCV treatment. 
  
Table 3.1 Geographical distribution of HCV genotypes: Predominant Hepatitis C 
genotype by region (I-BASE, 2008) (DDO limited) 
            HCV exists as a heterogenous population of different viruses, named as 
quasispecies within each infected individual (Murakawa K et.al. 1992). Lack of proof 
reading activity in RNA dependent RNA polymerase (RdRp) is the main reason for 
diversity in HCV genome which replicates the HCV RNA strand with an error rate of 
10-2 to 10-3 nucleotide substitutions per site per year (Natyszyn H. J. 2005). The 
enormous genetic variability is the major hurdle in developing antiviral therapy 
against HCV.  
3.1.3 Life cycle of HCV 
                 The life cycle of HCV is similar to other members of Flaviviridae family. 
Figure 3.1.2 depicts the main events in the life cycle of HCV. The life cycle begins 
with a) circulating infective HCV particles (virions) in the serum which interact with 
host lipoprotein receptor molecules at the cell surface. These virions are b) 
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internalized by catherin-mediated endocytosis of receptor-virus complex. Low pH of 
endocytic compartment results in the c) fusion of viral membrane with endosomal 
vesicle and thus the release of single-stranded , naked viral RNA into the cytoplasm 
of newly infected cell. The genomic RNA is d) translated by internal ribosomal entry 
site (IRES) – mediated translation to generate a single large polyprotein that is 
processed to produce 10 mature HCV proteins in association with virus derived ER-
like membrane structure termed as the membranous web. Progeny RNA is produced 
by the e) replication of RNA genome via a minus strand replicative intermediate. Few 
of the newly synthesized RNA is packaged into nucleocapsid, f) which bud from the 
ER after association with the HCV glycoproteins. Viral genomic RNA is g) 
transferred from membranous web to the nucelocapsid core protein that coats cellular 
lipid droplets and so the maturation of particles occur. Viral nucleocapsids h) bud into 
the ER and are released from the cell, thus completing the life cycle.  
     
      Figure 3.1.2 Schematic diagram of life cycle of HCV. (Figure adapted from 
Tellinghuisen T.L et. al. 2007). 
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3.1.4 Genome organization  
               The HCV genome is 9.6 kb positive strand uncapped RNA molecule with a 
single large open reading frame (ORF). It is flanked by highly structured and 
conserved 3’ and 5’ non-coding regions (Figure 3.1.3) (Tellinghuisen T.L et. al. 
2007). Translation of HCV genome depends on internal ribosome entry site (IRES) 
within 5’-noncoding region (NCR). The HCV, IRES binds to 40S ribosomal subunit 
(Spahn C. M. et al. 2001) and IRES-40S complex then recruits eukaryotic initiation 
factor (eIF) 3 and Met-tRNA-eIF2-GTP complex to form translationally active 80S 
complex (Ji H. et. al. 2004). The large ORF is translated to yield a polyprotein of 
3000 amino acids which is processed during and after translation by combination of 
host and viral proteases to release 10 proteins, which are two different kinds – 
structured and non-structured (NS) (Houghton et al 1991, Van Doorn et al 1994). 
Host proteases process the N-terminal part of polyprotein and release HCV structure 
proteins which are – Core protein, putative envelope proteins E1 and E2 which are 
glycosylated and a small protein p7. These are involved in the formation of viral 
particle by the assembly of RNA with core protein, E1 and E2 (Hijikata M. et.al. 
1991; Lin C. et.al.1994). The remaining part of polyprotein is processed by NS2 and 
NS3 viral proteases. NS2 cleaves at NS2/NS3 junction and release NS2 protein while 
NS3 catalyze cleavage at NS3/NS4A, NS4A/NS4B, NS4B/NS5A, NS5A/NS5B to 
release NS3, NS4A, NS4B, NS5A and NS5B unstructured HCV proteins (Hijikata M 
et.al. 1993).  
            HCV unstructured proteins NS3, NS4A, NS4B, NS5A and NS5B form a 
membrane-bound replication complex (RC), together with viral RNA and cellular 
proteins (El-Hage N. et.al. 2003).  NS3 is multifunctional with protease activity at N-
terminus and C-terminus displays helicase/NTPase activity (Kolykhalov A. A et.al
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2000). Helicase activity is essential for unwinding of RNA and thus for viral RNA 
synthesis. NS4A act as a cofactor for NS3 stability, protease activity as well as 
helicase activity (Failla C. et.al. 1994). NS4B is highly hydrophobic and induces the 
formation of membranous web structure by inducing specific changes to intracellular 
membrane (Egger D. et.al. 2002). NS4B, NS4A and NS3 associate with ER via NS4B 
while NS5A associates with ER through its N-terminal amphiphatic helix and NS5B 
through its C-terminal hydrophobic region. Synthesis of full-length negative strand 
RNA marks the beginning of HCV genome replication and it is catalyzed by NS5B 
(RNA dependent RNA polymerase, RdRp), which is the catalytic subunit for 
replication within this complex (Behrens S. E. et.al. 1996). Most of the HCV 
unstructured proteins involved in viral RNA synthesis process are associated with the 
host cell membrane and replication processes which like most of the positive-sense 
RNA viruses occurs in close association with host cell membrane (Hijikata et al., 
1993). Recent studies show that some cellular proteins interacts with HCV 
unstructured proteins NS5A and NS5B and are also involved in the HCV replication 
process.  
3.1.5 NS5B (RNA dependent RNA polymerase, RdRp) 
             The NS5B is positioned at the C-terminus of virally encoded HCV 
polyprotein of ~3000 amino acids. NS5B is membrane associated and is distributed in 
the perinuclear region (Hwang SB et.al.1997). It is 66 KDa protein with composition 
of 591 amino acids. The GDD motif which is the signature sequence for RdRp is 
located at Gly317-Asp318-Asp319 positions respectively. HCV NS5B functions as an 
RNA-dependent RNA polymerase as well as a RNA-binding protein that is required 
for viral RNA synthesis (Andino R. et al. 1993). NS5B structure details show that it is 
a typical ‘right handed’ polymerase similar to most of the RNA dependent RNA               
 62 
 
polymerase enzymes (Joyce C et.al. 1995). Its structural organization consists of Palm 
domain, finger domain and thumb domain, with catalytic site located at the palm 
domain (Figure 3.1.4). Thumb domain and palm domain encircle the active site 
located within the palm domain (Lesburg C. A et.al. 1999). Studies show that NS5B 
(RNA polymerase) interacts with human VAP both in vitro and in vivo, suggesting 
that it may serve as a membrane receptor for HCV replication complexes. 
  
Figure 3.1.3 HCV genome organization, polyprotein processing and topology. A) The 
HCV genome is single-stranded positive sense RNA encoding a single large open 
reading frame (ORF) of approximately 3000 amino acid residues. The translation of 
ORF, via IRES elements, generate a large polyprotein, with N-terminus one-third 
consisting of structured proteins and remaining C-terminus with unstructured proteins. 
Polyprotein is processes by host and viral proteases to produce 10 individual HCV 
proteins. B) HCV proteins localization/topology respective to ER membrane. 
(Adapted from Tellinghuisen T.L et.al. 2007). 
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Figure 3.1.4 Crystal Structure of NS5B describing the location of finger, palm and 
thumb domain. (O’Farrell D. et.al. 2003) 
3.1.6 VAP proteins 
             VAMP-associated proteins (vesicular associated membrane protein-associated 
proteins also known as synaptobrevin-associated proteins) are expressed in all 
eukaryotes and are type II integral membrane proteins (Kagiwada S. et.al. 1998; 
Nishimura Y. et al. 1999). The human VAP family protein includes VAPA, VAPB, 
VAPC, and several newly-identified spliced variants (Skehel PA et. al. 1995; 
Nishimura Y. et. al. 1999; Nachreiner T. et.al. 2010). These proteins have diverse 
functionality but share same structural organization (Figure 3.1.5). VAPA and VAPB 
are composed of three conserved domains, with N-terminal immunoglobulin-like β 
sheet MSP (Major Sperm Protein) domain that has 22% sequence identity to the 
nematode MSP protein (Sepensowol S. et. al. 1989), a central coiled-coil domain and 
C-terminal hydrophobic, membrane-anchoring domain. VAPA and VAPB show 60% 
homology in the sequence. One recently discovered VAP protein, named VAPC, is a 
splice variant of VAPB. It lacks coiled-coil domain as well as TM (transmembrane) 
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domain (Nishimura Y. et. al. 1999). VAP-C c-terminus from 71 to 99 amino acid 
residues shares no homology to VAP-A and VAP-B, due to the frameshift 
(Figure3.1.6). 
 
Figure 3.1.5 General domain organization of VAP protein, with N-terminal MSP 
domain, middle amphipathic coiled-coil domain and hydrophobic membrane-
anchoring C-terminal domain. 
 
Figure 3.1.6 Alignment of the amino acid sequences of hVAP-C with hVAP-B and 
hVAP-C. The asterisks indicate the amino acid residues that are identical. Sequence in 
box represents the signature sequence of VAP proteins. Yellow highlighted region 
represent splice variant region of VAP-C. 
                  They are ubiquitously detected in mammalian organs, including the heart, 
placenta, lung, liver, skeletal muscle, and pancreas (Nishimura Y. et. al. 1999), 
suggesting their diverse functionality. VAP was first identified in Aplysia californica, 
a marine mollusc as a VAMP/synaptobrevin-associated protein, by yeast two hybrid 
screens (Skehel et.al., 1995). Since then they have been identified in yeast, 
Drosophila, mice, rats and humans (Nikawa J. et al. 1995; Weir M.L. et al. 1998; 
Nishimura Y. et al., 1999; Skehel P.A. et al. 2000; Pennetta G. et al. 2002).  VAPs are 
involved in wide range of cellular processes mainly lipid transport and metabolism 
(Nikawa, J. et al. 1995; Kawano M. et. al., 2006), microtubule organization (Skehel 
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P.A et.al. 2000; Pannetta G et. al. 2002 ), and membrane trafficking (Skehel P.A et. 
al. 1995) and it does so by interacting with large number of interacellular proteins like 
SNARE proteins (Skehel P.A et. al. 1995), tubulin (Pannetta G et. al. 2002), 
occluding (Lapierre L.A et. al. 1999) and many more. They also interact among 
themselves through transmembrane domains to form homodimer or heterodimer. VAP 
proteins also show interaction with viral proteins like Norwalk virus nonstructure 
proteins (Ettayebi K et.al. 2003), HCV virus proteins (Hamamoto I et.al. 2005; Tu H. 
et.al. 1999) and cowpea virus proteins (Carette J.E. et. al. 2002).  
3.1.7 Interaction of VAP proteins with HCV proteins 
              VAPA and VAPB form homodimer or heterodimer through c-terminal 
transmembrane domain. Studies show that VAP-A and VAP-B interacts with NS5B 
through MSP domain and with NS5A via coiled-coil domain (Tu H. et. al 1999). The 
first 70 residues of VAPC are same as in VAPB and are 77% homologus to that of 
VAPA, suggesting that VAP-C also have inclination to bind to NS5B but as it lacks 
coiled-coil domain it cannot bind to NS5A. The results also prove the same. Kukihara 
H. et. al. (2009) by immunoprecipitation shows that VAP-C interacts with NS5B but 
not with NS5A and its expression in the cell interrupts the interaction of VAP-A and 
VAP-B to NS5B and thus impairs the HCV replication and particle formation of 
HCV.  VAPC is thus the negative regulator of HCV replication.  
                Gao L. et. al. (2003) (Figure 3.1.7 A) has proposed a model for HCV 
replication assembly formation and VAP proteins binding on the assembly. They 
hypothesize that after recruitment of NS4A-NS4B-NS5A on lipid raft via. NS4B, NS3 
also get recruited at lipid raft with the help of its cofactor NS4A. Since hVAP-33 
(VAP-A/VAP-B) could be localized on various types of membranes in the cell, NS5B 
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along with hVAP-33 (VAP-A/VAP-B) is then recruited to join NS4A-NS4B-NS5A 
and NS3 on the lipid raft. NS5A binds to the lipid membrane from the N-terminal 
while C-terminus of NS5B facilitates in its binding to the membrane. hVAP-33 act as 
a linker between NS5A and NS5B, it binds with NS5B by MSP domain which is at 
the N-terminus and to NS5A by coil-coiled domain. Figure 3.1.7 B is the adapted 
version of Figure 3.1.7 A and shows the inhibition of replication complex formation 
after the binding of N-terminus of VAP-C to NS5B. NS5B cannot anchor itself into 
the lipid raft membrane and is therefore dependent on the interaction of hVAP-33 
with NS5A and as VAPC cannot bind to NS5A, the complete replication assembly 
cannot be formed because of which HCV RNA replication cannot be executed. This 
characteristic of VAP-C is important and can be studied further for drug discovery 
against Hepatitis C. 
            
 Figure 3.1.7A) Model for the mechanism of formation of HCV replication complex 
on lipid raft. The uncleaved NS4A-4B-5A recruits to lipid raft through NS4B. NS3 
associates with lipid raft by binding to its cofactor NS4A. NS5B binds to h-VAP-A/h-
VAP-B and moves to lipid raft and form a complex with NS4A-4B-5A via the 
interaction between NS5B and NS5A. The mechanism of entry of RNA into this 




Figure 3.1.7 B) h-VAP-C binding to NS5B inhibits the formation of polymerase 
assembly complex and so inhibits viral RNA replication. 
3.1.8 Therapeutics for HCV  
               Even after so many years of HCV virus discovery there is no therapeutic 
vaccine for its treatment. Till now the standard of care (SOC) for HCV consist of 
combination drug of pegylated interferon–α and antiviral ribavirin. But this interferon 
(IFN)-based therapy however, has limited efﬁcacy against the major genotype 1 of 
HCV. This treatment has a success rate of only <50%, and is plagued with adverse 
effects (Ghany M.G. et. al. 2009; Schoggins J. et. al. 2011). New treatment regimens 
were required that are more efficacious and better tolerated by all patients. On May 
2011, FDA approved first direct acting antivirals (DAAs), Merck’s boceprevir 
(Victrelis) and Vertex’s telaprevir (Incivek). Although, these target wider HCV 
genotypes but must be taken with a broad-acting antiviral pill, ribavirin as well as 
with regular injections of pegylated interferon. Interferon stimulates the immune 
system but also shows side effects ranging from flu-like fatigue to severe depression 
to cardiac problems. Because of adverse reactions all patients cannot take advantages 
of therapy. Moreover these therapies are quite expensive and cannot reach the people 
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in under developed nations, were HCV cases are more than other parts. The table 
below (Table 3.1.2) shows the price range of these new HCV therapies.           
Table 3.1.2 Cost of updated HCV treatment with a protease inhibitor in United States 
(Swan T. 2011) 
 
Table 3.1.3 HCV Direct-Acting Antivirals (DAA) in Clinical Trial Phase II or III, or 
FDA-Approved (Adapted from Vachon M.L. et. al. 2011) 
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A lot more direct acting antivirals (DAA), some without inclusion of interferons 
targeted against HCV are in different phases of development (Table 3.1.3).  
              But a major concern for drug development is the emergence of drug resistant 
viruses under the selective pressures exerted by antiviral drugs. The intrinsic low 
fidelity of the HCV replication machinery and fast turnover rate (up to1012 virions 
produced each day) causes every single genome copied to contain at least one 
mutation (Ogata N et.al 1991). As a result there is coexistence of lots of variant 
species named quasispecies. 
             At present the two HCV viral enzymes, NS3/4A serine protease and the 
NS5B RdRp are the important targets for drug discovery (Behrens S.E. et.al. 1996), as 
they are amenable to the development of biochemical assays for inhibitor screening 
(Kwo P.Y. et.al. 2011). Targeting enzymatic pathways however, leads to rapid 
development of drug resistance (Kwo P.Y. et.al. 2011; Halfon P. et. al. 2011). 
Therefore, there is promising potential to target non-enzymatic processes such as 
those required for RNA replication.  
              A clinically successful HCV drug should be able to suppress all viral variants 
and inhibit emergence of resistant viruses. One approach to solve the problem is to 
target cellular proteins involved in viral replication. This can have advantage of 
higher genetic barrier to resistance and broader genotype coverage. VAPC which was 
recently identified to block the HCV RNA replication as well as HCV propagation by 






              As stated above, HCV is a world-wide problem and major reason for liver 
cancer and liver transplants. There is urgent need to find solution for this virus and 
one approach is to target the cellular proteins interacting with HCV proteins. The 
previous studies show the negative regulation of HCV replication by cellular protein, 
VAPC. This protein could be an important lead in the discovery of effective drug 
against HCV. In drug discovery, knowledge of the inhibitor site of action is crucial to 
guiding medicinal chemistry efforts. The aims of the research project are:  
1) The purpose of the project is to study the biophysical and structural properties 
of VAPC. 
2) To investigate the binding pattern of VAPC to HCV unstructured protein 
NS5B which helps to gain insight into the interaction details of VAPC and 
NS5B using NMR as a tool. 
       This study is important to discover the new drug lead for hepatitis, which 











3.2 MATERIAL AND METHOD 
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3.2.1 Vector Construction  
           The gene for VAPC was constructed by using VAPB construct (from Shi 
Jiahai), as N-terminal 70 residues of VAPC are homologous to VAPB. The primers 
were designed to clone N-terminal 70 residues form VAPB and longer primers were 
designed to synthesize C-terminal 29 residues and then overlapping primers were 
used to combine the two constructs and get full length VAPC. The full length VAPC 
was later used to design the truncated VAPC (VAPC43, VAPC31 and VAPC14) 
constructs. NS5B plasmid was constructed using pXJ40flag-NS5B construct (from 
Dr. Tan Yee Joe). It is a subtype 1b HCV-S1 isolate. The primers were designed so as 
to truncate the C-terminal 21 residues of full length NS5B. All the constructs were 
designed such that it has BamH1 restriction site at N-terminal and Xho-1 restriction 
site at C-terminal. The PCR product and vectors (VAPC-pET32a, NS5B-pET32a and 
VAPC43-pGEX-4T-1, VAPC31- pGEX-4T-1 and VAPC31- pGEX-4T-1) were 
double digested by BamH I and Xho I (New England Biolab) at 37℃ for 4 hours and 
subsequently purified by QIAquick Gel Extraction Kit (Qiagen). Ligation was then 
carried out at 16℃ overnight in the presence of T4 DNA Ligase (New England 
Biolab). The Colony screening was done by using E.coli DH5α for ligation. Plasmids 
were purified by QIAprep Spin Miniprep Kit 250 (Qiagen). All of the above 
experiments followed the protocols provided by the manufacturers. All the procedures 
were monitored by Agarose DNA electrophoresis (Bio-Rad). The DNA sequence was 
confirmed by automated DNA sequencing. 
3.2.2 Codon optimization  
               The original VAPC constructs when expressed in E.coli cells showed very 
poor expression. It had lot of amino acid residues, especially at C-terminus, whose 
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codons relative frequeny is very low in E.coli. So those codons were replaced by the 
codons, with high frequency E.coli codons by designing suitable primers. 
3.2.3 Preparation of Competent E.coli Cells  
         Overnight culture of DH5α or BL21 cells was diluted into 50 ml fresh LB broth 
(Bio Basic Inc.) at a ratio of 1:100. Cells were grown at 37℃ with shaking till OD600 
reached 0.5~0.6. Then cells were transferred into sterile centrifuge tubes and spun 
down at 4000×g for 5min. The cell pellet was then gently resuspended with 0.5 
volumes (25ml) of ice cold, sterile, fresh 50mM CaCl2 (Merck) and immediately 
incubated on ice for at least 20 min. After that, cells were centrifuged down again at 
4000×g for 5min. After discarding the supernatant, cells were resuspended with 0.1 
volumes (5ml) of cold 50mM CaCl2 containing 10% glycerol (BDH Laboratory 
Supplies). Cell resuspension was then distributed in aliquots into 1.5ml sterile 
eppendorf tubes. Competent cells were stored at -80℃ after quick frozen by liquid 
nitrogen.   
3.2.4 Transformation of E. coli Cells  
        1µl plasmid DNA was added to 100 µl of BL-21 competent cells and cells were 
then incubated on ice for 30 min, followed by a heat shock at 42℃ for 90 seconds and 
a subsequent incubation on ice for 2 min. Then 500µl of LB was added to the tube 
and incubated at 37℃ for 1hr. before plating cells onto LB plates containing ampicilin 
(final concentration of 100µg/ml). 
3.2.5 Protein Expression and Purification  
3.2.5.1 Expression and purification of full length VAPC and truncated constructs 
          The recombinant full length his-tag VAPC and GST-tagged VAPC-constructs 
were expressed in the bacterial strain BL21. A single colony was picked and 
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inoculated to ampicillin (final concentration of 100µg/ml) containing LB broth and 
kept in an incubator shaker at 37°C at 200rpm for overnight. This seed culture was 
used to inoculate 1L LB media (100µg/ml ampicillin) with ratio of 1:100. Briefly, the 
cells were cultured at 37℃ so as to reach OD of 0.6 at 600nm wavelength. The culture 
was then induced by IPTG with a final concentration of 0.4mM and kept for 
expression for 16 hours at 20℃. Cells were harvested by centrifugation at 6000rpm, 
Beckman JA 8.1000 rotor and disrupted in lysis buffer (50mM Tris-HCl buffer 
(pH7.5) with 150mM NaCl) by using ultra sonicator at 4℃. The soluble proteins were 
separated by ultracentrifugation at 18000rpm for 30 minutes at 4°C. The supernatant 
of the centrifuged lysate was allowed to bind with Nickel beads resin.  The  resin  was  
washed  with  buffer  A  [50mM  Tris-HCl  (pH  7.5), 150mM  NaCl, 20mM  
imidazole]. The  protein  elution  was performed using  buffer  B  [50mM  Tris-HCl  
(pH  7.5),  150mM  NaCl,  250mM  imidazole]. Full length his-tagged VAPC was 
subsequently purified by HPLC on a reverse-phase C8 column. The recombinant 
GST-VAPC truncated constructs were purified by Glutathione-Sepharose 4B resin. 
The  resin  was  washed  with  buffer  A  [50mM  Tris-HCl  (pH  7.5), 150mM  NaCl, 
20mM  imidazole] and after overnight in-gel digestion with thrombin respective 
protein/peptide was purified by HPLC on a reverse-phase C18 column. The identities 
of recombinant proteins described above were veriﬁed by MALDI-TOF mass 
spectrometry.  
3.2.5.2 Expression and purification of NS5B 
             For NS5B construct designing C-terminal 21 residues were truncated to 
design His tagged-pET32a-NS5B. The construct was expressed in BL-21 competent 
cell. A single colony was picked and inoculated to LB broth containing ampicillin 
(final concentration of 100µg/ml) along with 0.5% filter sterilized glucose (NS5B 
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initial expression experiments were failed because of its leaky expression. Addition of 
0.5% glucose overcame the problem of leaky expression) and kept in an incubator 
shaker at 37°C at 200rpm for overnight. This seed culture was used to inoculate 1L 
LB media (100µg/ml ampicillin and 0.5% filter sterilized glucose) with ratio of 1:100. 
Briefly, the cells were cultured at 37℃ so as to reach OD of 0.6 at 600nm wavelength. 
The culture was then induced by IPTG with a final concentration of 0.5mM and kept 
for expression for 16 hours at 20℃ at 180 rpm. Cells were harvested by centrifugation 
at 6000 rpm, Beckman JA 8.1000 rotor and disrupted in lysis buffer [(50mM Tris-HCl 
buffer (pH8.0) with 300mM NaCl, 0.1% Triton X-100, 10mM MgCl2 and protease 
inhibitor tablet (Roche)] by using ultra sonicator at 4℃. The supernatant of the 
centrifuged lysate was allowed to bind with Nickel beads resin.  The  resin  was  
washed  with  buffer  A  [50mM  Tris-HCl  (pH  8.0), 150mM  NaCl, 20mM  
imidazole]. The  protein  elution  was performed using  buffer  B  [50mM  Tris-HCl  
(pH  8.0), 500mM  NaCl,  250mM  imidazole]. 
            The eluted protein after Ni2+-affinity chromatography was dialyzed in buffer 
with 20mM Tris, 200mM NaCl and 10mM β-ME at pH8.5. It was then purified by 
affinity purification AKTA FPLC machine (Amersham Biosciences) using HiTrap 
Heparin column (GE healthcare) with buffer A composition of 20mM Tris, 200mM 
NaCl and 10mM β-ME at pH8.5 and buffer B of 20mM Tris, 2M NaCl and 10mM β-
ME at pH8.5. The eluted protein was dialyzed in 20mM Tris, 200mM NaCl and 
10mM β-ME at pH 7.5 and this was further subjected to gel filtration using HiLoad 
16/60 superdex75 column. For NMR experiments NS5B protein was later exchanged 
in 10mM phosphate buffer pH 6.5 and also containing 10mM DTT. The recombinant 




3.2.6 Preparation of Isotope Labeled Proteins  
            For heteronuclear NMR experiments, 15N-labeled proteins were prepared 
following the similar expression and purification procedures except that E.coli cells 
were cultured in the M9 minimal medium (Na2HPO4•12H2O 17.1g/L (J. T. Baker); 
KH2PO4 3g/L (J. T. Baker); NaCl 0.5g/L; (15NH4)2SO4 1g/L (Cambridge Isotope 
Laboratories Inc.); Glucose 4g/L (Sigma); MgSO4 1mM (Merck); Thiamine 2mg/L 
(Sigma); ampicillin 75mg/L). The (15NH4)2SO4 salt was used for 
15N labeling and for 
13C labelling, labeled Glucose (2g/L) was used. 
3.2.7 Determination of Protein Concentration by Spectroscopy  
            The protein concentration was measured at 280nm using the Beer-Lambert 
Law:   
                                                          A = ε∗l∗C,  
Where ε is the molar absorption coefficient (M-1cm-1), l is the path length (cm), and 
C is the protein concentration (M). The absorption A of a protein at 280nm depends 
on the content of Trp, Tyr, and Cys (disulfide bonds). 
3.2.8 Circular Dichroism Spectroscopy 
           CD experiments were performed on a Jasco J-810 spectropolarimeter equipped 
with a thermal controller using 1mm path length cuvette and 0.1nm spectra resolution. 
The far-UV (190-260 nm) CD experiment was done with a sample concentration of 
20µM in 10mM phosphate buffer at pH 6.5 at 25°C and near UV (250-360nm) with a 
sample concentration of 100µM also at 25°C. A final CD spectrum was obtained by 
adding and averaging data from three independent scans.  
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3.2.9 NMR experiments 
           The NMR samples of full length VAPC and its truncated constructs, VAPC43, 
VAPC31, VAPC14 and VAPC mutant were prepared by dissolving the lyophilized 
powder in 450µl of 10mM phosphate buffer pH 6.5 containing 10 mM DTT. 50µl 
D2O (10% of total protein sample) was later added to all NMR samples for NMR spin 
lock signal. 
            One-dimensional (1D) 1H NMR two-dimensional (2D) 1H–15N HSQC (Sattler 
M. 1999) experiments for full length VAPC were followed by backbone assignment 
by HNCACB and CBCACONH experiments and all these were carried out on Bruker 
Avance 800MHz NMR spectrometer at temperature of 298K. Two-dimensional 
NOESY (Jeener J. 1979) and TOCSY (Bax 1985) experiments were done for the 
backbone assignment of VAPC43. 
           For the titration experiments, the concentrated NS5B protein was added to 
VAPC full length and its constructs to reach a molar ratio of 1:1.5. Kd values were 
calculated from titration experiments of VAPC43 and VAPC14 with NS5B with the 
final molar ratio of 1: 2.75 using Datafit Software. Spectra processing and analysis 
was carried out using NMRview software (Johnson 2004). Sequence-specific 
assignments for VAPC full length were achieved through identification of spin 
systems in the HNCACB spectra, combined with sequential connectivities in the 
CBCACONH spectra, similarly sequence-specific assignments for the VAPC43 were 
achieved through identification of spin systems in the TOCSY spectra, combined with 
sequential NOE connectivities in the NOESY spectra (Wagner, Wuthrich 1982; 











3.3 RESULTS AND DISCUSSION 
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3.3.1 Protein purification 
                     VAPC constructs were first purified by affinity purification using Ni2+ 
beads or GST beads after which protein was purified by RP-HPLC. The RP-HPLC 
profiles of different VAPC constructs are shown in Figure 3.3.1A. The yield of VAPC 
full length was less (from 1liter media 50µM protein was obtained in 500µl buffer) as 
compared to VAPC43 and VAPC14 (1liter media gave ~100 µM and ~250 µM of 









                  As NS5B is a RNA binding protein, this protein was purified using heparin 
column after affinity purification with Ni2+ beads. After heparin column purification 
(Figure 3.3.1B Top) protein was further purified by Superdex200 column (Figure 
3.3.1B Bottom) to get very pure protein. The proteins purified were further used for 









3.3.2 Structure characterization of full length VAPC protein 
               Sequence analysis of VAPC shows (Figure 3.3.2 A) that it is abundant in 
amino acids P, S, R, K, E and Q which are found more frequently in unstructured 
proteins and are named as disorder promoting amino acids and is depleted in W, Y, F, 
C, I, L and N residues, called as order promoting amino acids which are found more 
in the folded proteins (Dunker A.K. et al. 2001; Williams R.M. et al. 2001).This is in 
agreement to the CD profile of VAPC. As shown in Figure 3.3.2 B, the CD spectrum 
of VAPC in aqueous buffer (10mM Na2HPO4, 10mM DTT pH6.5) had a maximal 
negative peak at ~198 nm and had no significant positive signal at 192nm. In addition, 
there existed a very small negative shoulder signal at ~225nm. All of these indicated 
that VAPC possess a random coil structure but could have propensity (because of 
small negative shoulder at ~225nm) to attain some partial structure. pH titration 
ranging from pH 3 to pH 7.3 (Figure 3.3.2 B) shows that VAPC appeared to become 
more disordered as the amplitude of the maximal negative signal increased at ~200 
nm.              
              The structural properties of the VAPC were further assessed by the NMR. 
The 1D experiment (Figure 3.3.2 C) shows very narrow dispersion ranging from ~7.0 
to 8.0ppm. Narrow dispersion is characteristic feature of unstructured proteins 
because they lack the hydrogen bond interactions at amide proton region and this 
results in severe overlapping in 2D [1H-15N]-HSQC spectra. HSQC [1H-15N] 
experiment is a sensitive probe to tertiary packing and it is evident from the Figure 
3.3.3 A that VAPC showed very narrow spectral dispersions over both dimensions 
(~1ppm over 1H and ~10ppm over 15N dimensions), indicating that VAPC lacks a 
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tight side-chain packing. In particular, the observed NMR cross peaks were only 
about 75, less than that expected for a 99-residue protein, thus indicating that slow  
 
Figure 3.3.2 A) Sequence of VAPC, residues with green color are found more 
frequently in unstructured proteins and in VAPC approx. 40% population is disorder 
promoting amino acids. B) Characterization of VAPC by CD spectrum; left panel 
shows the far UV spectra of VAPC and right panel depicts the pH titration CD 
spectrum of VAPC, where red color represents spectrum at pH 3.0 and blue color at 
pH 7.0 C) 1D 1H NMR of VAPC.  
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Figure 3.3.3 2D 1H15N HSQC A) VAPC 2D shows narrow dispersion and shows 
amino acids specific clustering (represented with red circles) B) HSQC and sequential 
assignment of VAPC. The HSQC spectrum was acquired on an 800MHz NMR 
spectrometer in a 20mM phosphate buffer (pH6.5). The assigned residues are labeled 




conformational exchanges or/and fast exchange with H2O existed over few regions of 
the protein. Usually, slow conformational exchange would result in significant line 
broadening for HSQC peaks and make these peaks undetectable. Consistent to the CD 
result, the HSQC spectrum above indicated that VAPC was unstructured. In addition 
to a lack of dispersion of the proton chemical shifts, 2D [1H 15N]-HSQC spectra of 
VAPC exhibit characteristic amino acid type specific clustering (Figure 3.3.3A). 
             Backbone assignments of VAPC (full length) was achieved for non-proline 
residues with the analysis of a pair of triple-resonance experiments, CBCA(CO)NH 
and  HNCACB, acquired on a 15N-/13C-labeled VAPC sample at a protein 
concentration of 300 µM and the assigned HSQC spectra are shown in Figure 3.3.3B. 
In total, 75% of the residues in the full length VAPC (1–99) were assigned (Cα and 
Cβ).  
              Lack of well defined 3-D structure has dramatic effect on carbon chemical 
shifts. The chemical shifts of Cα, Cβ, Co and Hα nuclei are highly sensitive to  Φ/Ψ 
angle propensities of the backbone (Eliezer et al. 1998), and so to the secondary 
structure. The chemical  shift  index  (CSI),  or  the  difference  between  experimental  
chemical  shifts  and random  coil  chemical  shifts (table 3.3.1),  can  be  used to  
determine  secondary  structure  in  proteins (Szilagyi and Jardetzky 1989; Wishart 
and Sykes 1994). The Cα CSI is positive in an α-helix and negative in a β-strand and 
for VAPC Cα CSI it was found that it is closer to the random coil chemical shift 
values, again conforming that VAPC is a predominantly unstructured protein. As is 
evident from Figure 3.3.4, CSI of VAPC for most of the residues is even less than 
0.2ppm. For few residues it reaches around 1-1.5ppm but that is insignificant as to 
have structure, at least 4 to 5 continuous residues should have CSI value of around 
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0.7ppm (Wishart and Sykes 1994b). All the experiments above confirm that VAPC is 
an intrinsically unstructured protein. 
 
Table 3.3.1 Random Coil Chemical shifts (in ppm) for the 20 common amino acids in 
acidic 8 M urea (Adapted from Schwarzinger S. et.al. 2000) 
 
Figure 3.3.4 Cα chemical shift values of VAPC for most residues collapse with the 
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3.3.3 VAPC forms a “fuzzy” complex with NS5B 
             Recent studies show that VAPC interacts with NS5B protein of HCV and 
inhibits the replication process of virus. For the interaction studies of VAPC with 
NS5B, we purified the HCV NS5B protein and characterized it with CD and NMR. 
The far-UV CD (Figure 3.3.5 A) spectrum of NS5B shows characteristic of a well-
folded helix-dominant protein, with two negative signals at ~209 and 222 nm, as well 
as a very large positive signal at ~193 nm. However, due to the short transverse 
relaxation time (T2) resulting from its very large molecular size, the NMR resonance 
peaks are very broad (Figure 3.3.5 B). But the presence of several highly up-field 
signals clearly demonstrate that NS5B is well folded, with a tight tertiary packing in 
solution. 
        
Figure 3.3.5 A) The far UV CD spectra of NS5B shows to negative signals at ~209 
and 222 nm respectively B) 1D 1H NMR of VAPC, the blue arrows points towards the 
up-field peaks. 
               Subsequently, unlabelled NS5B was titrated with labeled VAPC and to 
characterize the binding interactions, two-dimensional  1H-15N HSQC spectra of the 
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15N-labelled VAPC was acquired with a protein concentration of ~100µM in the 
absence of NS5B followed by constant addition of NS5B in the molar ration of 1:0.5, 
1:1 and 1:1.5 (VAPC:NS5B). The shifted residues of VAPC were assigned by 
superimposing the HSQC spectra in the absence and presence of the NS5B. The 
degree of perturbation was evaluated by an averaged chemical shift according to the 
formula [(∆1H)2+(∆15N/4)2]1/2(ppm). Addition of NS5B triggered the shifts of many 
HSQC peaks of VAPC(Figure 3.3.5 C), indicating that VAPC was indeed able to bind 
to NS5B but most of the residues which show perturbation on interaction with NS5B 
are mainly located at the C-terminus of VAPC.  It is also important to note that the 
HSQC spectral dispersions of VAPC did not significantly increase even upon binding 
to NS5B, implying that VAPC remained largely flexible even in the complex (Figure 
3.3.5 D). 
 
Figure 3.3.5 C) Titration experiment of VAPC to HCV NS5B C) CSD calculation of 






















Figure 3.3.5 Titration experiment of VAPC to HCV NS5B D) VAPC 2D spectrum 
with perturbed peaks. Black peaks represent the VAPC spectrum without NS5B, blue 
peaks represent the VAPC spectrum with NS5B in molar ratio of 1:1.5 (VAPC: 
NS5B) 
3.3.4 VAPC C-terminal constructs 
             Based on interaction of full length VAPC to HCV NS5B, we designed 
different VAPC constructs with truncation/removal of N-terminus. The constructs 
were named as VAPC43, VAPC31 and VAPC14 (Figure 3.3.6). VAPC43 consist of 
C-terminal 43 residues, starting with asparagine57. Titration of full length VAPC with 
NS5B (Figure 3.3.5 A) shows that the C–terminus of VAPC is mainly involved in 
binding with NS5B and the binding region begins from serine58 and so we truncated 
full length VAPC from residue 57 to get VAPC43. VAPC14 was designed based on 
titration of VAPC43 with NS5B (discussed later) and so the more tightly binding 
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residues were truncated to get VAPC14. But VAPC31 was not studied very 
extensively as initial experiments shows the aggregation behavior did not show very 
tight interaction of this construct with NS5B as compared to other two constructs. 
 
Figure 3.3.6 Representation of VAPC c-terminal constructs. Black box (1) represents 
c-terminal 43 residues (VAPC43), red box (2) represents c-terminal 31 residues 
(VAPC31) and green box represents 14 residues with further truncation of c-terminus. 
3.3.4.1 Structural characterization of VAPC43, VAPC31 and VAPC14 
          The structural properties of all VAPC truncated constructs (VAPC43, VAPC31 
and VAPC14) were first investigated by CD spectroscopy. The CD spectrum of all the 
constructs was collected in buffer with 10mM Na2HPO4 pH 6.5 at protein 
concentration of ~20µM. All the spectrums (Figure 3.3.7 A) showed the same pattern, 
with a maximal negative peak at ~202nm and no signal at any other wavelength. 
Implying, like full length VAPC, all the constructs are without any folded structure. 
The same observation was made for NMR experiments. The 1D spectrum for 
VAPC43, VAPC31 and VAPC14 had narrow dispersion from ~7.0 to 8.0ppm and as 
explained in the previous section this narrow dispersion is the characteristic of 
unstructured proteins.  
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Figure 3.3.7 Top panel shows the CD spectrum of VAPC43, VAPC31 and VAPC14, 
all have similar kind of spectrum with negative peak at ~202nm. Bottom panel 
represents the 1D spectrum of three constructs. Both kind of experiments confirms 






Figure 3.3.8A) HSQC and sequential assignments of VAPC43. The spectra were 
acquired on an 800MHz NMR spectrometer in a 20mM phosphate buffer (pH6.5). 
The assigned residues are labeled in the spectra. 
 
Figure 3.3.8B) HSQC and sequential assignments of VAPC14. The spectra were 
acquired on an 800MHz NMR spectrometer in a 20mM phosphate buffer (pH6.5). 
The assigned residues are labeled in the spectra.   
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To gain residue-specific insights into the solution conformation of VAPC-43, we 
collected a pair of three-dimensional heteronuclear NMR spectra, namely 15N-edited 
HSQC-TOCSY and HSQC-NOESY, and subsequently achieved its sequential 
assignment. The sequence-specific backbone assignment for VAPC14 and VAPC31 
was achieved by comparing the almost identical resonance dispersion of VAPC43 on 
the1H-15N HSQC spectra. The proton [1H] chemical shift values of VAPC43 were 
used to calculate the chemical shift index (CSI) of VAPC43 by subtracting the 
random coil proton [1H] chemical shift values (table 3.3.1). Hα(observed)- 
Hα(random coil) ssp (secondary structure propensity) scores of VAPC43 are  shown  
in  Figure 3.3.8. The Hα CSI is negative in an α-helix. For VAPC43 although Hα CSI 
was negative but its value was not substantial. As is evident from Figure3.3.9, CSI of 
VAPC43 [1Hα] for all the residues was very low. It was closer to the random coil 
values hence suggesting the unstructured nature of VAPC43. 
                    Based on characteristic NOEs patterns (Figure3.3.9) including dNN(i, i + 
2), dαN(i, i +3), and dαN(i, i + 4), as well as  αH conformational shifts , it was very 
clear that VAPC43 does not have any well defined and folded structure. The existence 
of the loop or helical-like segments was supported by characteristic NOEs (Figure 
3.3.10) over the VAPC-43 sequence defining the helical conformation, including 
dNN(i, i+1), dNN(i, i+2), dαN(i, i+2), and dαN(i, i+3). However, since no dαN(i, i+4) NOEs were 
observed, the helical conformation in VAPC-43 appeared to be mainly dynamic 310-
helix/loop, rather than α-helix, consistent with the above CD result.  
                 Structure modeling of VAPC43 using CYANA shows that the protein had 
no folded structure. Figure 3.3.11 shows ten superimposed structures calculated from 
CYANA. Six out of ten structures did not show any helix conformation. But four of 
the structures showed a small helix at residues 79, 80, 81 and 82 and one of the 
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structures out of these four also had a small helix at 60, 61, 62 and 63. Moreover, the 
calculated structure was found to be very much flexible at the C-terminal region.  
 
Figure 3.3.9 Hα CSD (Chemical shift deviation) plot of VAPC43 shows the values in 
close proximity to the random coil values. 
 
Figure 3.3.10 NOE pattern representation for VAPC43. 
               




3.3.3.2 Interaction of VAPC43 with HCV NS5B 
                    Monitoring the perturbations of 15N and 1H chemical shifts of HSQC 
spectra upon binding to a ligand is commonly used to map residues involved in 
interaction. So to characterize the binding interactions of VAPC43 with NS5B, two-
dimensional 1H-15N HSQC spectra of the 15N-labelled VAPC43 was acquired with a 
protein concentration of ~100µM in the absence of NS5B, and unlabeled NS5B was 
added stepwise up to a final molar ratio of 1:2.75 (VAPC43:NS5B), with each step 
monitored by acquiring 2D1H-15N HSQC spectrum. The shifted residues of VAPC 
constructs were assigned by superimposing the HSQC spectra in the absence and 
presence of the NS5B. Figure 3.3.12 A shows the superimposition of the 1H-15N 
HSQC spectrum of free protein [VAPC43 shown in red] and protein in complex with 
HCV NS5B (shown in blue). A series of titrations  with corresponding molar ratios 
(protein:ligand) 1:0, 1:0.25, 1:0.5, 1:0.75, 1:1, 1:1.25, 1:1.50, 1:1.75, 1:2.0, 1:2.50 and 
1:2.75 were carried out to obtain chemical shift changes at different ligand 
concentrations for VAPC4:NS5B. The degree of perturbation was then evaluated by 
an averaged chemical shift according to the formula [(∆1H)2+(∆15N/4)2]1/2 (ppm). By 
carefully analyzing the spectra we observe that the saturation point was reached at 
around 1.5 to 1.75 molar ratio of NS5B meaning that the peaks didn’t show any 
further perturbation. Almost all the peaks showed the shift but the most perturbed 
peaks for VAPC 43 spectrum were I61, R73, W74, E78, E77, D80, S81, A81, W94, 
E95 and E98. Although VAPC43 is highly unstructured in solution, but the HSQC 





Figure 3.3.12 A) 2D [1H-15N] HSQC of VAPC43 on titration to HCV NS5B, red 
color represents the HSQC spectrum of VAPC43 without NS5B, green represents the 
spectrum with VAPC43:NS5B molar ratio of 1:1.0 and blue represents VAPC:NS5B 
ratio of 1:2.75. The satellite picture shows example of peaks (R73 & W74) which get 
perturbed on addition of NS5B, with black line represents the distance between the 
unperturbed and perturbed peaks. 
            However, even at a molar ratio of 1:2.5 (VAPC-43:NS5B) where the peak 
shifting of many residues were largely saturated (Figure 3.12 B), the HSQC spectral 
dispersions still remained largely unchanged. This implies that like the full-length 
VAPC, VAPC-43 also remains largely flexible without any tight tertiary packing in  
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the complex with NS5B. A vigilant observation of CSD graph suggests that VAPC43 
has three binding pockets through which it binds to NS5B. It has an N-terminal 
pocket which consists of amino acid I61, C-terminal pocket with residues W94, E95 
and R98 and a central pocket with R73, W74, E78, E79, D80, S81 and A82 residues. 
 
Figure 3.3.12B) CSD chart for VAPC43, where blue bar represents titration point at 
VAPC43:NS5B molar ratio of 1:0.5, green bar at 1:1 and red bar at 1:2.75. The CSD 
data shows the presence of three binding pockets: small pockets at N-terminal and C-
terminal with one binding pocket at the centre. 
To identify the importance of second binding pocket of VAPC43 in binding to 
NS5B, we mutated four residues (Arg73, Trp74, Glu78 and Asp80) into Ala. The 
mutated construct (pGEX-4T-1-VAPC43Mut) was successfully expressed and 
purified. Like VAPC43, the VAPC-43 mutant appeared to be highly unstructured 
without any well-formed secondary structures as judged from its far-UV spectrum 
(Figure 3.3.12 C), and lacked any tight tertiary packing as demonstrated by the very 
narrow HSQC spectral dispersions (Figure 3.3.12 D).  The intensities of its HSQC 
peaks of VAPC-mutant were not uniform, i.e. some were very strong but some very 
weak. This possibly could be because of some dynamic aggregation, or/and 
conformational exchanges on µs to ms time-scale (Figure 3.3.12 D). Titration result of 
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labeled VAPC-43 mutant with unlabeled NS5B shows the importance of  second 
pocket of VAPC43 in binding to NS5B as, even at a molar ratio of 1:2.5 (VAPC-43 
mutant:NS5B), no significant shift of the HSQC peaks was observed (Figure 3.3.11 
D), which clearly demonstrates  that this second region is indeed critical for binding 
with NS5B. 
 
Figure 3.3.12 C) Representation of far UV CD spectra of VAPC43-mutant shows that 
VAPC43-mutant is unstructured. D) 2D HSQC of VAPC43: blue peaks represents 
free VAPC43-mutant whereas pink and red are in the presence of NS5B in the ratio of 
1:1.5 and 1:2.5 respectively. 
                We also studied VAPC31 construct for its binding with NS5B but for this 
construct peak intensities were weak which could be because of dynamic aggregation 
or fast conformational exchange (Figure 3.3.12 D) and so this construct was not 
included for further studies. 
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Figure 3.3.12 D) 2D [1H-15N] HSQC of VAPC31 on titration to HCV NS5B, black 
color represents the HSQC spectrum of VAPC31 without NS5B and blue represents 
VAPC:NS5B in molar ratio of 1:2.0 
 
3.3.3.3 Interaction of VAPC14 with NS5B 
Based on the titration results of VAPC43-wild type and VAPC43-mutant, another 
construct, VAPC14 was subjected to titration experiments with NS5B. Again, even at 
a molar ratio of 1:2.5 (VAPC-14:NS5B), the HSQC spectral dispersions still remained 
largely unchanged (Figure 3.3.13 A). This indicates that like the full-length VAPC 
and VAPC-43, even in the complex with NS5B, VAPC-14 remained largely flexible 
without any tight tertiary packing. Although, all the residues showed perturbation but 
the observation of CSD graph (Figure 3.3.13 B) shows that the most perturbed peaks 
were D77, E78, E79, D80, E83 and Q85. Removal of N and C-terminals affects the 
binding affinity with HCV NS5B. This can be observed from the dissociation constant 





Figure 3.3.13 A) 2D [1H-15N] HSQC of VAPC14 on titration to HCV NS5B, black 
color represents the HSQC spectrum of VAPC14 without NS5B and blue represents 
VAPC:NS5B in molar ratio of 1:2.5 
 
Figure 3.3.13 B) The CSD representations of VAPC14 on binding to NS5B at 







3.3.4 Determination of dissociation constant (Kd) through HSQC titration 
            Our attempts to measure the binding constant of VAPC with NS5B failed, 
which could probably be due to the complex binding mode, and/or the fact that many 
VAPC residues still remain largely flexible even in the complex. So as to 
quantitatively access the binding between VAPC-43/VAPC-14 and NS5B, the 
dissociation constant (Kd) was calculated by fitting the chemical shift values from 
different titration points into the equation below and it was done using software 
Datafit 7.1 (Oakdale). 
δ = δmax × {1/2+0.5X + Kd/[P] - [1/4 +(0.5X + Kd/2[P])
2  
+ Kd/2[P] – 0.5X] 
1/2
} 
δmax and Kd are separate variables that are adjusted to produce the best fit of 
calculated to observed data (Macomber R. S. et. al. 1992). A binding isotherm may be 
calculated with knowledge of the complex stoichiometry, this forms the principle of 
curve fitting methods.  
          Fitting data was generated for the residues which showed high degree of 
perturbation as compared to other residues. Figure 3.3.14 A represents the fitting 
curve for N-terminal (I61) and C-terminal (E95) binding pockets of VAPC43 and 
Figure 3.3.13 B represents the fitting curves for the central binding pocket of 
VAPC43. Fitting curve for VAPC14 is represented in Figure 3.3.14. The Kd values 
obtained by fitting in the Datafit software are shown in table 3.3.2. The average Kd 
value for VAPC43 was 18.29 µM and for VAPC14 it was 49.13 µM. Interestingly, 
comparing the Kd values shows that the deletion of first and third binding pocket 





    
 
Residues 
          VAPC43            VAPC14 
      Kd (µM) ± SD       Kd (µM) ± SD 
I61      1.269 ±  19.536  
R72  161.318 ± 63.857 
R73       41.397 ± 19.536  
W74        19.932 ± 5.371  
D77     17.18 ± 5.76 
E78        0.01 ± 0.07     18.032 ± 3.315 
E79        5.526 ± 2.058      1.41 ± 1.34 
D80        4.348 ± 2.152    68.877 ± 18.928 
A82        0.01±0.22    27.34 ± 12.63 
E83       18.62 ± 3.32 
Q85        0.11 ± 0.2 
E95        20.265 ± 7.632  
Average         18.29 ± 7.35   49.13 ± 17.64 
        
Table 3.3.2 Kd values with SD (standard deviation) of shifted residues from VAPC43 
and VAPC 14. (underlined Kd values have large errors, and thus were not included 
for calculating the average Kd values) 







Figure 3.3.14 Shows the final fitting curves of most perturbed residues in the three 
pockets of VAPC43 A) Fitting curve for N (I61) and C-terminal (E95) pocket (B) 
Fitting curve for the centre pocket residues. 
 
                     





             Most of the RNA viruses, such as HCV form the replication complexes 
associated with the host membrane (Johnson B.A et.al. 1994). Currently knowledge is 
very less about the structure of the complexes but it is anticipated that studies of RNA 
virus replication machineries will have a critical impact on antiviral drug development 
due to their specific roles in virus replication (Johnson B.A. et.al. 1994). In vivo 
studies show a cellular protein VAPC is the negative regulator for HCV replication 
and it does so by inhibiting the RNA dependent RNA polymerase (RdRp) activity. 
Although it is been more than a decade now but till date no in-vitro data is available 
for the structure as well as for the binding characterization of VAPC and NS5B. By 
studying the structure of VAPC along with its interaction with NS5B using NMR as a 
tool, we for the first time provide the detailed study of VAPC and HCV NS5B 
interaction at the residue level. 
              For VAPC, very limited knowledge is available about its functional roles 
particularly no structure study data have been reported for this protein till date. The 
human VAPC is a 99-residue splicing variant of the 243-residue VAPB, with the N-
terminal 70 residues being identical in both proteins. Protein sequence analysis shows 
that VAPC contained high percentage of disorder promoting amino acids. The 
absence of a well-defined structure was confirmed by CD and NMR spectroscopy and 
by use of these techniques; we provide here the first residue-specific evidence that 
VAPC is in fact highly unstructured in solution, lacking any stable secondary 
structure and tight tertiary packing.  Upon binding to NS5B, there is no observed 
conformational change in VAPC. The three binding pockets remain connected by the 
flexible loops. As a consequence, our study suggests that VAPC is a new member of 
so-called ‘‘intrinsically unstructured protein (IUP)’’ family which represents an 
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expanding category of proteins of being biologically active but highly unstructured 
under physiological conditions. The recent discovery of IUPs (intrinsically 
unstructured proteins) have challenged the decades old paradigm that to be 
functionally active a protein needs to have a stable, 3D structure. It is now recognized 
that a large portion of proteins encoded by the eukaryotic genome (>30%) are IUPs 
(Tompa P. 2002; Dyson H.J et.al. 2005). Highly flexible and random-coil 
conformation is the native and functional state of many proteins and same is the 
situation for VAPC.  
               NMR characterization allows the identification of VAPC residues critical for 
binding to NS5B. The results show that VAPC interacts with NS5B, but through c-
terminal. Interestingly, it appears that three discrete VAPC regions are involved in 
binding with NS5B. The first (N-terminal binding pocket) and third (C-terminal 
binding pocket) regions are relatively small and are centered at Ile62 and Glu95 
respectively, while the second region is much longer, spanning residues from Arg73-
Ala82. Interestingly, the sequence analysis shows that only the first binding pocket is 
located within the identical sequence of VAPC and VAPB, while the second and third 
are both within the VAPC unique sequence. The importance of the second region was 
further confirmed by characterizing a VAPC-43 mutant which dramatically lost 
binding ability to NS5B. The dissociation constant (Kd) value for VAPC43 upon 
binding with NS5B is 18.29µM. Removal of N-terminal binding pocket or C-terminal 
binding pocket or both have negative effect on the interaction with NS5B. VAPC14 is 
the construct without N and C-terminal binding pockets and its Kd value is 49.13µM. 
Although the dissociation constant value for VAPC14 is thrice as much as compared 
to VAPC43, but still it is in the moderately tight binding range. This small VAPC 
fragment can be used for further studies and can be a target for drug design against 
 105 
 
HCV. In conclusion, VAPC-14 may be useful for exploring the biological functions 
of VAPC in vivo, and also represents a promising starting point to develop potent 
peptide inhibitors for interfering with the VAPC-NS5B interface in the treatment of 
HCV infection by use of NMR-guided approaches. 
3.3.6 Future Directions 
          VAPC14 can be good target for drug design since the interaction surface is not 
only typically smaller but is also more easily defined. For future work, VAPC14 can 
be used to co-crystallize with HCV NS5B, so as to check the exact location of NS5B 
residues which are involved in binding with VAPC. As it is reported that VAPC 
inhibits NS5B activity, it is necessary to do the RNA dependent RNA polymerase 
assay (RdRp) for NS5B and check the inhibitory activity of VAPC as well as its 
truncated constructs (VAPC43 and VAPC14). Functional study of these fragments 
can also give a clear picture of VAPC-NS5B interaction pattern. Moreover, VAPC is 
an unstructured protein and it is highly possible that it is involved in some other 
interactions with host or viral proteins, so it will be quite interesting as well as 
challenging to find out the interacting partners of VAPC and their functional impact. 
VAPC is the hopeful target and further work can help to develop it as an effective 
drug against HCV, which will be resistant to mutagenesis and will be effective against 





























              Viral infection result in millions of deaths each year. Millions of dollars are 
spent annually to better understand how virus infect their hosts and to identify 
potential targets for therapeutics. An important aspect of host virus system is the 
mechanism by which a virus is able to invade a host cell. Within these complex 
systems, protein-protein interactions (PPIs) between surface proteins form the 
foundation of communication between a host and a virus and play a vital role in 
initiating infection.  The study of the interactions among viral and host factors provide 
the data to create novel therapeutic strategies and the development of new antiviral 
drugs (Huang L. et. al. 1998). The two proteins studied, viperin and VAPC also have 
been known to inhibit virus through protein-protein interactions.  
4.1 Association of Viperin and VAP proteins 
               Viperin and VAPC are recently discovered antiviral proteins. Since its 
discovery in 1997 viperin has constantly been observed to have antiviral properties 
against multiple viruses ranging from DNA virus to RNA virus (Chapter 2.1). 
Mechanism of action of viperin against most of these viruses is still not known. But 
its activity against HCV seems to be associated with hVAP-33 (VAPA) (Helbig K.J. 
et.al. 2011). Just like VAPC, viperin also inhibits HCV by disrupting the formation of 
replication complex. Viperin inhibits HCV replication by interfering with the 
association of NS5A with lipid droplets. Recent studies show the interaction between 
viperin and hVAP-33. As discussed before hVAP-33 is a host protein and is required 
for the formation of HCV RNA replication complex on lipid droplets. The HCV 
protein NS5A bind to the coiled-coil domain and NS5B bind to the MSP domain of 
hVAP-33 during the formation of replication complex.NS5B cannot anchor itself into 
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the lipid raft membrane and is therefore dependent on the interaction of hVAP-33 
with NS5A. Interaction of viperin with hVAP-33 disrupts hVAP-33 interaction with 
NS5A and thus results in the inhibition of formation of HCV replication complex. 
            This suggests that Viperin binds to NS5A whereas VAPC binds to NS5B to 
disrupt the replication complex formation and thus lead to inhibition of HCV.  So 
viperin along with VAP proteins could be an effective target for hepatitis c virus. 
There are lot more host cell factors which are under study for hepatitis c. Some of 
them have been identified and have been proposed to use as targets for antiviral 
development. Because HCV variants with one or two nucleotide substitutions are 
generated every day, which implies that resistant-to-treatment mutants could be 
generated daily. In this respect, host cell factors have emerged as a promising 
alternative. They reduce the risk of development of antiviral resistance and they 
increase the chance for broad spectrum activity, by covering all HCV genotypes. The 
search, identification and characterization of host proteins involved in virus life 
cycles, have become a hot spot in virology during the last years. The few important 
targets identified for HCV, other than VAP and Viperin are cyclophilins (Fisher G. et. 
al 1989), FK506-binding proteins (FKBP) (Siekierka JJ et.al. 1989a; 1989b) and 
parvulins (Rahfeld JU et.al.1994) and the secondary amide peptide bond cis/trans 
isomerase (APIase) (Schiene-Fischer C et.al. 2002). 
 
4.2 Other Cellular proteins as target for antiviral drugs  
              Viral infection of mammalian cells results in the activation of a number of 
viral recognition pathways triggered by replication intermediates and/or viral proteins 
that ultimately induce innate defenses to limit viral replication (Helbig K.J. et.al. 
2011). Pivotal to this antiviral response is the induction of IFN. Interferon forms the 
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first line of defense in viral infection. The interferon response is capable of controlling 
most virus infections, even in the absence of an adaptive immune response. The type I 
IFNs (IFN-α and β) are essential for immune defenses against viruses and, after 
binding to the type I IFN receptor, induce the expression of hundreds of interferon-
stimulated genes (ISGs), many of which act to limit viral replication. ISGs may have 
direct or indirect antiviral action (Sen G.C 2001). Although the structure study of 
these proteins along with their binding partners is a very challenging work but it will 
have a great impact upon drug design and drug discovery field. Some of the proteins 
which are known to have antiviral activities and can be studied in future are, ISG15 
(IFN-stimulated protein of 15 kDa) (Osiak A. et.al. 2005), the GTPase Mx1 
(myxovirus resistance 1) (Melén K et. al. 1994), ribonuclease L (RNaseL) and protein 
kinase R (Takizawa T et. al. 2002) (PKR; also known as EIF2αK2). Some additional 
ISGs that probably also have important roles in antiviral activities include: the 
deaminases ADAR1 (adenosine deaminase, RNA-specific 1) and APOBEC 
(apolipoprotein B mRNA-editing enzyme, catalytic polypeptide) protein; the 
exonuclease ISG20; members of the tripartite-motif containing (TRIM) proteins such 
as TRIM19 (also known as PML); and the highly IFN-induced translation regulators 
IFIT1 (IFN-induced protein with tetratricopeptide repeats 1) and IFIT2. All of these 
ISGs have been reported to function as antiviral proteins in vitro but the complete 
spectrum of antiviral ISGs and their mechanisms of action remain to be elucidated. 
Further investigation using the appropriate gene knockout mouse models is needed for 
a better understanding of their relative importance in the antiviral response.  
                By understanding at the molecular level how viruses counteract the host 
immune response and understanding the mechanism of interactions between viral and 
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